KCmax的个人主页 - 老虎社区

KCmax

KCmax

暂无个人介绍

IP属地：未知

354关注

31粉丝

0主题

0勋章

2021-12-14

Please like, thanks!

抱歉，原内容已删除

2021-12-12

Please like, thank you!

抱歉，原内容已删除

2021-12-10

Please like, thank you

抱歉，原内容已删除

2021-12-09

Please like, thank you 🙏🏻

抱歉，原内容已删除

2021-12-08

Please like, thanks

抱歉，原内容已删除

2021-12-06

Please like, thanks

Grab shares slid more than 4% in premarket trading

2021-12-03

Please like, thanks

Novavax stock surged more than 7% in premarket trading

2021-12-02

Please like, thanks

抱歉，原内容已删除

2021-11-30

Please like, thanks

Covid-19 Antibody Drugs Are Challenged by Omicron, Preliminary Testing Indicates

2021-11-28

Please like, thanks

抱歉，原内容已删除

2021-11-26

Please like, thanks

Fear, Not Calculated Trading, Is Behind Today’s Covid Market Crash

2021-11-26

Please like, thanks

Faraday Future shares fell more than 6% in premarket trading

2021-11-12

Please like, thanks!

Why the hottest inflation in 3 decades isn’t rattling stock-market bulls

2021-11-09

Please like, thanks!

Luminar shares soared nearly 70% in premarket trading

2021-11-04

Please like, thanks!

抱歉，原内容已删除

2021-11-03

Please like, thanks

@期权小班长:电动车走势不理想？推荐一种舒适的赚钱方法

2021-10-29

Please like, thank you

抱歉，原内容已删除

2021-10-26

Please like, thanks!

AMD earnings look to again succeed where Intel disappointed

2021-10-25

Please like, thanks

US IPO Week Ahead: Semiconductors, energy storage, designer apparel, and more in a 12 IPO week

2021-10-21

Please like, thanks!

Weekly jobless claims fall to fresh pandemic-era low of 290,000

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4088005490387040","uuid":"4088005490387040","gmtCreate":1624902445965,"gmtModify":1626959242200,"name":"KCmax","pinyin":"kcmax","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":31,"headSize":354,"tweetSize":72,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.37%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.13","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.19%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":607925391,"gmtCreate":1639477651128,"gmtModify":1639477651495,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks!","listText":"Please like, thanks!","text":"Please like, thanks!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607925391","repostId":"1121800259","repostType":4,"isVote":1,"tweetType":1,"viewCount":2420,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604914113,"gmtCreate":1639307329305,"gmtModify":1639307329652,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thank you!","listText":"Please like, thank you!","text":"Please like, thank you!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604914113","repostId":"2190679207","repostType":4,"isVote":1,"tweetType":1,"viewCount":2120,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605890559,"gmtCreate":1639140185647,"gmtModify":1639140186020,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thank you","listText":"Please like, thank you","text":"Please like, thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/605890559","repostId":"1100115506","repostType":4,"isVote":1,"tweetType":1,"viewCount":2396,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602596365,"gmtCreate":1639038079165,"gmtModify":1639038079482,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thank you 🙏🏻&nbsp;","listText":"Please like, thank you 🙏🏻&nbsp;","text":"Please like, thank you 🙏🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602596365","repostId":"1160927591","repostType":4,"isVote":1,"tweetType":1,"viewCount":2773,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602368027,"gmtCreate":1638973718285,"gmtModify":1638973718679,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks&nbsp;","listText":"Please like, thanks&nbsp;","text":"Please like, thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/602368027","repostId":"1180032077","repostType":4,"isVote":1,"tweetType":1,"viewCount":3050,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608740082,"gmtCreate":1638794956515,"gmtModify":1638795937524,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks","listText":"Please like, thanks","text":"Please like, thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/608740082","repostId":"1191828969","repostType":4,"repost":{"id":"1191828969","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638792831,"share":"https://www.laohu8.com/m/news/1191828969?lang=&edition=full","pubTime":"2021-12-06 20:13","market":"us","language":"en","title":"Grab shares slid more than 4% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1191828969","media":"Tiger Newspress","summary":"Grab shares slid more than 4% in premarket trading.The&nbsp;Singapore ride-hailing firm&nbsp;went on sale last week.","content":"<p>Grab shares slid more than 4% in premarket trading.The&nbsp;Singapore ride-hailing firm&nbsp;went on sale last week.</p>\n<p><img src=\"https://static.tigerbbs.com/8de30b544b65a645e7a91a37bfb8d8f8\" tg-width=\"851\" tg-height=\"618\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Grab shares slid more than 4% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGrab shares slid more than 4% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-06 20:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Grab shares slid more than 4% in premarket trading.The&nbsp;Singapore ride-hailing firm&nbsp;went on sale last week.</p>\n<p><img src=\"https://static.tigerbbs.com/8de30b544b65a645e7a91a37bfb8d8f8\" tg-width=\"851\" tg-height=\"618\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRAB":"Grab Holdings"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191828969","content_text":"Grab shares slid more than 4% in premarket trading.The Singapore ride-hailing firm went on sale last week.","news_type":1,"symbols_score_info":{"GRAB":0.9}},"isVote":1,"tweetType":1,"viewCount":2262,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601667375,"gmtCreate":1638523686919,"gmtModify":1638523690134,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks","listText":"Please like, thanks","text":"Please like, thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/601667375","repostId":"1154256555","repostType":4,"repost":{"id":"1154256555","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638523084,"share":"https://www.laohu8.com/m/news/1154256555?lang=&edition=full","pubTime":"2021-12-03 17:18","market":"us","language":"en","title":"Novavax stock surged more than 7% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1154256555","media":"Tiger Newspress","summary":"Novavax stock surged more than 7% in premarket trading as Novavax said it could start making Omicron","content":"<p>Novavax stock surged more than 7% in premarket trading&nbsp;as&nbsp;Novavax said it could start making Omicron-specific vaccine in January.</p>\n<p><img src=\"https://static.tigerbbs.com/25019bf4a8dc635b8734c21361f7c7d0\" tg-width=\"852\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p>\n<p>Novavax Inc&nbsp;said on Thursday it could begin commercial manufacturing of a COVID-19 vaccine tailored for the Omicron coronavirus variant in January next year, while it tests whether or not its current vaccine works against the variant.</p>\n<p>Laboratory data expected in the coming weeks will show whether antibodies from individuals who have previously received Novavax's COVID-19 shot can neutralize the variant, according to the company.</p>\n<p>Novavax also said it has started developing an Omicron-specific spike protein antigen and will begin laboratory tests of a new vaccine to target the variant in a few weeks.</p>\n<p>The Omicron coronavirus variant has shaken up markets and caused global alarm over concerns about whether it could evade protection provided by widely used vaccines and prolong the public health crisis.</p>\n<p>Other vaccine makers including Moderna&nbsp;and Pfizer&nbsp;have also begun working on Omicron-tailored COVID-19 shots.</p>\n<p>Novavax's COVID-19 vaccine received its first emergency use approval in Indonesia in early November followed by the Philippines.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax stock surged more than 7% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax stock surged more than 7% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-03 17:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax stock surged more than 7% in premarket trading&nbsp;as&nbsp;Novavax said it could start making Omicron-specific vaccine in January.</p>\n<p><img src=\"https://static.tigerbbs.com/25019bf4a8dc635b8734c21361f7c7d0\" tg-width=\"852\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p>\n<p>Novavax Inc&nbsp;said on Thursday it could begin commercial manufacturing of a COVID-19 vaccine tailored for the Omicron coronavirus variant in January next year, while it tests whether or not its current vaccine works against the variant.</p>\n<p>Laboratory data expected in the coming weeks will show whether antibodies from individuals who have previously received Novavax's COVID-19 shot can neutralize the variant, according to the company.</p>\n<p>Novavax also said it has started developing an Omicron-specific spike protein antigen and will begin laboratory tests of a new vaccine to target the variant in a few weeks.</p>\n<p>The Omicron coronavirus variant has shaken up markets and caused global alarm over concerns about whether it could evade protection provided by widely used vaccines and prolong the public health crisis.</p>\n<p>Other vaccine makers including Moderna&nbsp;and Pfizer&nbsp;have also begun working on Omicron-tailored COVID-19 shots.</p>\n<p>Novavax's COVID-19 vaccine received its first emergency use approval in Indonesia in early November followed by the Philippines.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154256555","content_text":"Novavax stock surged more than 7% in premarket trading as Novavax said it could start making Omicron-specific vaccine in January.\n\nNovavax Inc said on Thursday it could begin commercial manufacturing of a COVID-19 vaccine tailored for the Omicron coronavirus variant in January next year, while it tests whether or not its current vaccine works against the variant.\nLaboratory data expected in the coming weeks will show whether antibodies from individuals who have previously received Novavax's COVID-19 shot can neutralize the variant, according to the company.\nNovavax also said it has started developing an Omicron-specific spike protein antigen and will begin laboratory tests of a new vaccine to target the variant in a few weeks.\nThe Omicron coronavirus variant has shaken up markets and caused global alarm over concerns about whether it could evade protection provided by widely used vaccines and prolong the public health crisis.\nOther vaccine makers including Moderna and Pfizer have also begun working on Omicron-tailored COVID-19 shots.\nNovavax's COVID-19 vaccine received its first emergency use approval in Indonesia in early November followed by the Philippines.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":3196,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603478246,"gmtCreate":1638446759894,"gmtModify":1638446760055,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks","listText":"Please like, thanks","text":"Please like, thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603478246","repostId":"1180366088","repostType":4,"isVote":1,"tweetType":1,"viewCount":2526,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609694359,"gmtCreate":1638275659492,"gmtModify":1638275659636,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks","listText":"Please like, thanks","text":"Please like, thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/609694359","repostId":"1192203085","repostType":4,"repost":{"id":"1192203085","kind":"news","pubTimestamp":1638273550,"share":"https://www.laohu8.com/m/news/1192203085?lang=&edition=full","pubTime":"2021-11-30 19:59","market":"us","language":"en","title":"Covid-19 Antibody Drugs Are Challenged by Omicron, Preliminary Testing Indicates","url":"https://stock-news.laohu8.com/highlight/detail?id=1192203085","media":"The Wall Street Journal","summary":"Regeneron said its antibody drug cocktail was found to lose effectiveness against the new variant\nA ","content":"<p>Regeneron said its antibody drug cocktail was found to lose effectiveness against the new variant</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ed6086131617e6933fe07f3e46cd5c26\" tg-width=\"1290\" tg-height=\"859\" referrerpolicy=\"no-referrer\"><span>A monoclonal antibody treatment site in Pembroke Pines, Fla., earlier this year.</span></p>\n<p>Preliminary tests indicate the Covid-19 antibody drug cocktail from Regeneron Pharmaceuticals Inc. loses effectiveness against Omicron, the company said Tuesday, a sign that some products in an important class of therapies might need modifying if the new strain becomes widespread.</p>\n<p>Separate testing of another authorized Covid-19 antibody drug cocktail, from&nbsp;Eli Lilly&amp; Co., indicates it also isn’t as effective against Omicron, outside scientists said. Lilly said it is testing the new variant against its antibody treatment and wouldn’t speculate on what the results will be.</p>\n<p>The findings are the early results of researchers’ race to assess the impact of the&nbsp;new Omicron variant&nbsp;on Covid-19 treatments that patients, doctors and hospitals have been relying on, as well as pills in development that have promised to keep people out of the hospital.</p>\n<p>Researchers say some antibody therapies are likely to be especially vulnerable to Omicron because it contains mutations to the spike protein that the Regeneron and Lilly drugs target, while other drugs should hold up well because they attack elements of the virus unchanged in the variant.</p>\n<p>Monoclonal antibodies are lab-made molecules derived from survivors of Covid-19 or mice engineered to have human immune systems. When given soon after infection, the drugs attach to the surface of the coronavirus and prevent it from replicating itself in new cells.</p>\n<p>They are the only drugs authorized to treat patients, before they require hospitalization, who are at high risk of developing severe cases.</p>\n<p>The drugs differ from vaccines, which train the immune system how to defend against the virus, including with the production of antibodies. Last year, former&nbsp;President Donald Trump credited Regeneron’s drug&nbsp;with his speedy recovery from Covid-19.</p>\n<p>Regeneron said it would be able to quantify the impact of the variant in coming weeks, after further testing is done.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6e7fac5c4630025e6c5ad28d2c3efbfa\" tg-width=\"1050\" tg-height=\"700\" referrerpolicy=\"no-referrer\"><span>Antiviral pills such as Pfizer’s Paxlovid appear to be unaffected by the variant.</span></p>\n<p>If final testing shows that its antibody drugs are less effective against Omicron, Regeneron has developed alternative antibodies that it can push into clinical testing and that it thinks will retain effectiveness against the variant, said George Yancopoulos, the company’s president and chief scientific officer.</p>\n<p>One of Regeneron’s alternative antibodies is already in clinical testing, which the company began in anticipation of new variants emerging over time.</p>\n<p>The Omicron variant was identified last week by scientists in South Africa, prompting drug researchers to scramble to see if the relatively small medicine chest of Covid-19 treatments would still work against the new strain if it ends up spreading widely.</p>\n<p>“What we have to admit is, in the course of the past six days, our urgency has increased,” Dr. Yancopoulos said in an interview. “What started out as a backup plan has now been made a lot more urgent.”</p>\n<p>Scientists at the Fred Hutchinson Cancer Research Center in Seattle found that individual mutations from Omicron reduced or eliminated the ability of Regeneron’s and Lilly’s drugs to attach to the virus, said Allie Greaney, a Ph.D. candidate at the center and the University of Washington in Seattle.</p>\n<p>More comprehensive tests of the drugs against the entire variant are needed to fully understand the impact, she said. “I’m not certain what the exact magnitude of effect would be, but probably less effective,” said Ms. Greaney.</p>\n<p>Lilly is in the process of testing the new variant against its drug, a combination of&nbsp;two antibodies called bamlanivimab and etesevimab,said Nicole Kallewaard, a Lilly virologist and research adviser.</p>\n<p>She declined to comment on the results showing reduced effectiveness against individual Omicron mutations, because the results may differ when all of the mutations are combined.</p>\n<p>“I think that we need to wait for confirmation of the whole virus,” said Dr. Kallewaard. “Hopefully, the data will come in the next few weeks.”</p>\n<p>A rise in the prevalence of Omicron could present an opportunity for competitors who say their drugs don’t appear in preliminary testing to be affected by the variant, including&nbsp;Vir Biotechnology&nbsp;Inc.&nbsp;and GlaxoSmithKline PLC, whose drug&nbsp;sotrovimab was authorized for emergency use&nbsp;earlier this year.</p>\n<p>Fred Hutchinson researchers also said their initial testing indicated the Vir-GSK antibody drug retained its effectiveness.</p>\n<p>Adagio Therapeutics&nbsp;Inc.,a biotech with a Covid-19 antibody drug in clinical trials, said its antibody also appears to be unaffected by the new variant.</p>\n<p>Vir, Glaxo and Adagio said they are conducting further tests to confirm that their drugs aren’t affected by Omicron.</p>\n<p>Omicron poses a threat to lab-made antibody drugs as well as antibodies generated by vaccines, because the new variant has mutations on the spike protein part of the virus where antibodies are known to frequently attach themselves, scientists say.</p>\n<p>Vir and Adagio officials said the companies designed their antibodies with the aim of targeting spots on the virus that are common across different coronaviruses that remained stable even after numerous mutations over many years.</p>\n<p>“They bind to a region of the virus that through decades of evolution has not changed a lot,” Adagio Chief Executive Tillman Gerngross said in an interview. “Those conserved areas make the virus much more vulnerable” to antibodies.</p>\n<p>It will take at least two weeks to create a version of the full Omicron virus variant and test antibody drugs against it, company officials said. Still, scientists say they are concerned by what they know already about the variant’s ability to evade antibodies produced by vaccines, prior infection or from drug treatment.</p>\n<p>“Omicron hasn’t become the next Delta,” Vir Chief Scientific Officer Skip Virgin said in an interview. But “we think the extent of the mutations, the number of them, means that the world needs to take Omicron very seriously.”</p>\n<p>Antiviral drugs, including pills from&nbsp;Merck&amp; Co. and partner Ridgeback Biotherapeutics LP and from&nbsp;Pfizer&nbsp;Inc.&nbsp;that are being&nbsp;evaluated for authorization,appear to be unaffected by the variant because they target a different site on the virus, said Michel Nussenzweig, an immunologist at Rockefeller University.</p>\n<p>Doctors and patients have been looking forward to authorization of the pills, which in clinical trials have&nbsp;reduced the risk of hospitalization&nbsp;if taken early enough.</p>\n<p>“The targets of the pills appear to be under less pressure and may be OK, but this too needs to be tested,” said Dr. Nussenzweig.</p>\n<p>Pfizer and Merck said they expect their drugs to be effective against Omicron.</p>\n<p>Gilead SciencesInc.&nbsp;also said it expects&nbsp;Veklury, its antiviral drug&nbsp;used to treat hospitalized patients, to retain effectiveness against Omicron as it has against other variants of concern.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Covid-19 Antibody Drugs Are Challenged by Omicron, Preliminary Testing Indicates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCovid-19 Antibody Drugs Are Challenged by Omicron, Preliminary Testing Indicates\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 19:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/covid-19-antibody-drugs-are-challenged-by-omicron-preliminary-testing-indicates-11638270003?mod=Searchresults_pos1&page=1><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Regeneron said its antibody drug cocktail was found to lose effectiveness against the new variant\nA monoclonal antibody treatment site in Pembroke Pines, Fla., earlier this year.\nPreliminary tests ...</p>\n\n<a href=\"https://www.wsj.com/articles/covid-19-antibody-drugs-are-challenged-by-omicron-preliminary-testing-indicates-11638270003?mod=Searchresults_pos1&page=1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来","REGN":"再生元制药公司"},"source_url":"https://www.wsj.com/articles/covid-19-antibody-drugs-are-challenged-by-omicron-preliminary-testing-indicates-11638270003?mod=Searchresults_pos1&page=1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1192203085","content_text":"Regeneron said its antibody drug cocktail was found to lose effectiveness against the new variant\nA monoclonal antibody treatment site in Pembroke Pines, Fla., earlier this year.\nPreliminary tests indicate the Covid-19 antibody drug cocktail from Regeneron Pharmaceuticals Inc. loses effectiveness against Omicron, the company said Tuesday, a sign that some products in an important class of therapies might need modifying if the new strain becomes widespread.\nSeparate testing of another authorized Covid-19 antibody drug cocktail, from Eli Lilly& Co., indicates it also isn’t as effective against Omicron, outside scientists said. Lilly said it is testing the new variant against its antibody treatment and wouldn’t speculate on what the results will be.\nThe findings are the early results of researchers’ race to assess the impact of the new Omicron variant on Covid-19 treatments that patients, doctors and hospitals have been relying on, as well as pills in development that have promised to keep people out of the hospital.\nResearchers say some antibody therapies are likely to be especially vulnerable to Omicron because it contains mutations to the spike protein that the Regeneron and Lilly drugs target, while other drugs should hold up well because they attack elements of the virus unchanged in the variant.\nMonoclonal antibodies are lab-made molecules derived from survivors of Covid-19 or mice engineered to have human immune systems. When given soon after infection, the drugs attach to the surface of the coronavirus and prevent it from replicating itself in new cells.\nThey are the only drugs authorized to treat patients, before they require hospitalization, who are at high risk of developing severe cases.\nThe drugs differ from vaccines, which train the immune system how to defend against the virus, including with the production of antibodies. Last year, former President Donald Trump credited Regeneron’s drug with his speedy recovery from Covid-19.\nRegeneron said it would be able to quantify the impact of the variant in coming weeks, after further testing is done.\nAntiviral pills such as Pfizer’s Paxlovid appear to be unaffected by the variant.\nIf final testing shows that its antibody drugs are less effective against Omicron, Regeneron has developed alternative antibodies that it can push into clinical testing and that it thinks will retain effectiveness against the variant, said George Yancopoulos, the company’s president and chief scientific officer.\nOne of Regeneron’s alternative antibodies is already in clinical testing, which the company began in anticipation of new variants emerging over time.\nThe Omicron variant was identified last week by scientists in South Africa, prompting drug researchers to scramble to see if the relatively small medicine chest of Covid-19 treatments would still work against the new strain if it ends up spreading widely.\n“What we have to admit is, in the course of the past six days, our urgency has increased,” Dr. Yancopoulos said in an interview. “What started out as a backup plan has now been made a lot more urgent.”\nScientists at the Fred Hutchinson Cancer Research Center in Seattle found that individual mutations from Omicron reduced or eliminated the ability of Regeneron’s and Lilly’s drugs to attach to the virus, said Allie Greaney, a Ph.D. candidate at the center and the University of Washington in Seattle.\nMore comprehensive tests of the drugs against the entire variant are needed to fully understand the impact, she said. “I’m not certain what the exact magnitude of effect would be, but probably less effective,” said Ms. Greaney.\nLilly is in the process of testing the new variant against its drug, a combination of two antibodies called bamlanivimab and etesevimab,said Nicole Kallewaard, a Lilly virologist and research adviser.\nShe declined to comment on the results showing reduced effectiveness against individual Omicron mutations, because the results may differ when all of the mutations are combined.\n“I think that we need to wait for confirmation of the whole virus,” said Dr. Kallewaard. “Hopefully, the data will come in the next few weeks.”\nA rise in the prevalence of Omicron could present an opportunity for competitors who say their drugs don’t appear in preliminary testing to be affected by the variant, including Vir Biotechnology Inc. and GlaxoSmithKline PLC, whose drug sotrovimab was authorized for emergency use earlier this year.\nFred Hutchinson researchers also said their initial testing indicated the Vir-GSK antibody drug retained its effectiveness.\nAdagio Therapeutics Inc.,a biotech with a Covid-19 antibody drug in clinical trials, said its antibody also appears to be unaffected by the new variant.\nVir, Glaxo and Adagio said they are conducting further tests to confirm that their drugs aren’t affected by Omicron.\nOmicron poses a threat to lab-made antibody drugs as well as antibodies generated by vaccines, because the new variant has mutations on the spike protein part of the virus where antibodies are known to frequently attach themselves, scientists say.\nVir and Adagio officials said the companies designed their antibodies with the aim of targeting spots on the virus that are common across different coronaviruses that remained stable even after numerous mutations over many years.\n“They bind to a region of the virus that through decades of evolution has not changed a lot,” Adagio Chief Executive Tillman Gerngross said in an interview. “Those conserved areas make the virus much more vulnerable” to antibodies.\nIt will take at least two weeks to create a version of the full Omicron virus variant and test antibody drugs against it, company officials said. Still, scientists say they are concerned by what they know already about the variant’s ability to evade antibodies produced by vaccines, prior infection or from drug treatment.\n“Omicron hasn’t become the next Delta,” Vir Chief Scientific Officer Skip Virgin said in an interview. But “we think the extent of the mutations, the number of them, means that the world needs to take Omicron very seriously.”\nAntiviral drugs, including pills from Merck& Co. and partner Ridgeback Biotherapeutics LP and from Pfizer Inc. that are being evaluated for authorization,appear to be unaffected by the variant because they target a different site on the virus, said Michel Nussenzweig, an immunologist at Rockefeller University.\nDoctors and patients have been looking forward to authorization of the pills, which in clinical trials have reduced the risk of hospitalization if taken early enough.\n“The targets of the pills appear to be under less pressure and may be OK, but this too needs to be tested,” said Dr. Nussenzweig.\nPfizer and Merck said they expect their drugs to be effective against Omicron.\nGilead SciencesInc. also said it expects Veklury, its antiviral drug used to treat hospitalized patients, to retain effectiveness against Omicron as it has against other variants of concern.","news_type":1,"symbols_score_info":{"LLY":0.9,"REGN":0.9}},"isVote":1,"tweetType":1,"viewCount":2409,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600839486,"gmtCreate":1638114455737,"gmtModify":1638114455964,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks&nbsp;","listText":"Please like, thanks&nbsp;","text":"Please like, thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/600839486","repostId":"2186432895","repostType":4,"isVote":1,"tweetType":1,"viewCount":1767,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877285184,"gmtCreate":1637936240818,"gmtModify":1637936240989,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks","listText":"Please like, thanks","text":"Please like, thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877285184","repostId":"1145084508","repostType":4,"repost":{"id":"1145084508","kind":"news","pubTimestamp":1637929067,"share":"https://www.laohu8.com/m/news/1145084508?lang=&edition=full","pubTime":"2021-11-26 20:17","market":"us","language":"en","title":"Fear, Not Calculated Trading, Is Behind Today’s Covid Market Crash","url":"https://stock-news.laohu8.com/highlight/detail?id=1145084508","media":"Barrons","summary":"Gathering over Thanksgiving may have lulled many into feeling that the pandemic is over. Looking at ","content":"<p>Gathering over Thanksgiving may have lulled many into feeling that the pandemic is over. Looking at the stock market today will shatter that illusion.</p>\n<p>Concerns around a new, heavily-mutated variant of Covid-19 identified in South Africa have rocked investor confidence. Stocks are plunging around the world, oil prices are dropping, bond yields are sliding—even Bitcoin is feeling the heat. There is a broad reversion to frenzied, theme-based trading. Vaccine stocks and pandemic plays like Zoom are surging while airline stocks are falling.</p>\n<p>What we are seeing is fear and uncertainty. Sell first, ask questions later. And low trading volumes globally due to the Thanksgiving holiday is likely exacerbating volatility.</p>\n<p>What we are not seeing is markets intelligently pricing in the impact of this new development. Scientific experts have yet to draw conclusions about the mutation, known for now as B.1.1.529, and there are less than 100 confirmed cases.</p>\n<p>That’s not to say fear is misplaced. Early indications are that B.1.1.529 is significantly different from other variants, and, truly, the worst case scenario is that it’s more deadly, contagious, and vaccine-resistant than what we’ve already faced.</p>\n<p>But we don’t know that yet. Similar market shockwaves caused by the Delta variant over the summer eventually subsided. Though it led to a surge in cases around the world, modern science was able to tackle it and move on. Hopefully the same can be said of this variant.</p>\n<p>But for now investors will have to put up with heightened uncertainty—the markets’ worst enemy.</p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fear, Not Calculated Trading, Is Behind Today’s Covid Market Crash</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFear, Not Calculated Trading, Is Behind Today’s Covid Market Crash\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-26 20:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/articles/things-to-know-today-51637926639?mod=newsviewer_click><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gathering over Thanksgiving may have lulled many into feeling that the pandemic is over. Looking at the stock market today will shatter that illusion.\nConcerns around a new, heavily-mutated variant of...</p>\n\n<a href=\"https://www.marketwatch.com/articles/things-to-know-today-51637926639?mod=newsviewer_click\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"https://www.marketwatch.com/articles/things-to-know-today-51637926639?mod=newsviewer_click","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1145084508","content_text":"Gathering over Thanksgiving may have lulled many into feeling that the pandemic is over. Looking at the stock market today will shatter that illusion.\nConcerns around a new, heavily-mutated variant of Covid-19 identified in South Africa have rocked investor confidence. Stocks are plunging around the world, oil prices are dropping, bond yields are sliding—even Bitcoin is feeling the heat. There is a broad reversion to frenzied, theme-based trading. Vaccine stocks and pandemic plays like Zoom are surging while airline stocks are falling.\nWhat we are seeing is fear and uncertainty. Sell first, ask questions later. And low trading volumes globally due to the Thanksgiving holiday is likely exacerbating volatility.\nWhat we are not seeing is markets intelligently pricing in the impact of this new development. Scientific experts have yet to draw conclusions about the mutation, known for now as B.1.1.529, and there are less than 100 confirmed cases.\nThat’s not to say fear is misplaced. Early indications are that B.1.1.529 is significantly different from other variants, and, truly, the worst case scenario is that it’s more deadly, contagious, and vaccine-resistant than what we’ve already faced.\nBut we don’t know that yet. Similar market shockwaves caused by the Delta variant over the summer eventually subsided. Though it led to a surge in cases around the world, modern science was able to tackle it and move on. Hopefully the same can be said of this variant.\nBut for now investors will have to put up with heightened uncertainty—the markets’ worst enemy.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":454,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877616941,"gmtCreate":1637923303506,"gmtModify":1637923303645,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks","listText":"Please like, thanks","text":"Please like, thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877616941","repostId":"1152215880","repostType":4,"repost":{"id":"1152215880","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637918015,"share":"https://www.laohu8.com/m/news/1152215880?lang=&edition=full","pubTime":"2021-11-26 17:13","market":"us","language":"en","title":"Faraday Future shares fell more than 6% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1152215880","media":"Tiger Newspress","summary":"Faraday Future shares fell more than 6% in premarket trading, the company received anticipated lette","content":"<p>Faraday Future shares fell more than 6%&nbsp;in premarket&nbsp;trading,&nbsp;the&nbsp;company&nbsp;received&nbsp;anticipated letter from Nasdaq regarding form 10-Q filing&nbsp;previously.<img src=\"https://static.tigerbbs.com/131b60ba8d077deacc9e4e195922823f\" tg-width=\"941\" tg-height=\"634\" referrerpolicy=\"no-referrer\">The Company previously filed a Form 12b-25 with the Securities and Exchange Commission on November 15, 2021, disclosing that the Company’s board of directors formed a special committee of independent directors (the “Special Committee”) to investigate allegations of inaccurate disclosures, including claims contained in a report issued by an investor with a history of seeking to drive down public companies’ stock prices for its own benefit. The Special Committee has engaged outside counsel to conduct an independent review of such allegations. The review is ongoing, and the Special Committee continues to work diligently with outside counsel and advisors to complete the review as soon as possible. The Company cannot predict the duration of the review, eventual scope, its outcome, or its impact on the Company’s financial results.</p>\n<p>As noted in the Form 12b-25, the Company is working diligently towards the goal of being in a position to file the Q3 Form 10-Q, as well as its Form 8-K with the Company’s third quarter 2021 earnings press release and its amended Registration Statement on Form S-1 as soon as practicable after the conclusion of the review, but at this time cannot predict with certainty when the preparation and filing of those forms will be completed. The Company intends to timely submit a plan to regain compliance to the Nasdaq Listing Qualifications Department. During this time, and for the extension period which may be granted to the Company by the Nasdaq Listing Qualifications Department, the Company’s securities will continue to be listed on Nasdaq. Upon the Company’s filing of its Q3 Form 10-Q, the Company will again become compliant with Nasdaq Marketplace Rule 5250(c)(1).</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Faraday Future shares fell more than 6% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFaraday Future shares fell more than 6% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-26 17:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Faraday Future shares fell more than 6%&nbsp;in premarket&nbsp;trading,&nbsp;the&nbsp;company&nbsp;received&nbsp;anticipated letter from Nasdaq regarding form 10-Q filing&nbsp;previously.<img src=\"https://static.tigerbbs.com/131b60ba8d077deacc9e4e195922823f\" tg-width=\"941\" tg-height=\"634\" referrerpolicy=\"no-referrer\">The Company previously filed a Form 12b-25 with the Securities and Exchange Commission on November 15, 2021, disclosing that the Company’s board of directors formed a special committee of independent directors (the “Special Committee”) to investigate allegations of inaccurate disclosures, including claims contained in a report issued by an investor with a history of seeking to drive down public companies’ stock prices for its own benefit. The Special Committee has engaged outside counsel to conduct an independent review of such allegations. The review is ongoing, and the Special Committee continues to work diligently with outside counsel and advisors to complete the review as soon as possible. The Company cannot predict the duration of the review, eventual scope, its outcome, or its impact on the Company’s financial results.</p>\n<p>As noted in the Form 12b-25, the Company is working diligently towards the goal of being in a position to file the Q3 Form 10-Q, as well as its Form 8-K with the Company’s third quarter 2021 earnings press release and its amended Registration Statement on Form S-1 as soon as practicable after the conclusion of the review, but at this time cannot predict with certainty when the preparation and filing of those forms will be completed. The Company intends to timely submit a plan to regain compliance to the Nasdaq Listing Qualifications Department. During this time, and for the extension period which may be granted to the Company by the Nasdaq Listing Qualifications Department, the Company’s securities will continue to be listed on Nasdaq. Upon the Company’s filing of its Q3 Form 10-Q, the Company will again become compliant with Nasdaq Marketplace Rule 5250(c)(1).</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1152215880","content_text":"Faraday Future shares fell more than 6% in premarket trading, the company received anticipated letter from Nasdaq regarding form 10-Q filing previously.The Company previously filed a Form 12b-25 with the Securities and Exchange Commission on November 15, 2021, disclosing that the Company’s board of directors formed a special committee of independent directors (the “Special Committee”) to investigate allegations of inaccurate disclosures, including claims contained in a report issued by an investor with a history of seeking to drive down public companies’ stock prices for its own benefit. The Special Committee has engaged outside counsel to conduct an independent review of such allegations. The review is ongoing, and the Special Committee continues to work diligently with outside counsel and advisors to complete the review as soon as possible. The Company cannot predict the duration of the review, eventual scope, its outcome, or its impact on the Company’s financial results.\nAs noted in the Form 12b-25, the Company is working diligently towards the goal of being in a position to file the Q3 Form 10-Q, as well as its Form 8-K with the Company’s third quarter 2021 earnings press release and its amended Registration Statement on Form S-1 as soon as practicable after the conclusion of the review, but at this time cannot predict with certainty when the preparation and filing of those forms will be completed. The Company intends to timely submit a plan to regain compliance to the Nasdaq Listing Qualifications Department. During this time, and for the extension period which may be granted to the Company by the Nasdaq Listing Qualifications Department, the Company’s securities will continue to be listed on Nasdaq. Upon the Company’s filing of its Q3 Form 10-Q, the Company will again become compliant with Nasdaq Marketplace Rule 5250(c)(1).","news_type":1,"symbols_score_info":{"FFIE":0.9}},"isVote":1,"tweetType":1,"viewCount":397,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879611243,"gmtCreate":1636715530802,"gmtModify":1636715530939,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks!","listText":"Please like, thanks!","text":"Please like, thanks!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/879611243","repostId":"1144158970","repostType":4,"repost":{"id":"1144158970","kind":"news","pubTimestamp":1636702548,"share":"https://www.laohu8.com/m/news/1144158970?lang=&edition=full","pubTime":"2021-11-12 15:35","market":"us","language":"en","title":"Why the hottest inflation in 3 decades isn’t rattling stock-market bulls","url":"https://stock-news.laohu8.com/highlight/detail?id=1144158970","media":"Marketwatch","summary":"Stock market investors still aren’t sweating rising inflation pressures that saw U.S. consumer price","content":"<p>Stock market investors still aren’t sweating rising inflation pressures that saw U.S. consumer prices rise 6.2% year-over-year in October, a nearly 31-year high. And that might not change until the Federal Reserve gets more aggressive, analysts said.</p>\n<p>“U.S. equities have shrugged off this year’s surge in inflation, probably because it has not coincided with either a rise in the real yields of Treasurys or weakness in corporate earnings,” said Oliver Allen, markets economist at Capital Economics, in a Thursday note. The real yield is the yield an investor receives after accounting for inflation.</p>\n<p>Markets were briefly roiled following the October Consumer Price Index reading on Wednesday. Nominal Treasury yields rose sharply, weighing on stocks, particularly technology and other growth-oriented sectors seen as most sensitive to rising interest rates.</p>\n<p>Equities were stable Thursday, while the Treasury market was closed for the U.S. Veterans Day holiday. The tech-heavy Nasdaq Composite , which fell more than 1% on Wednesday, was up 0.7% Thursday, while the S&amp;P 500&nbsp;edged up 0.1% and the Dow Jones Industrial Average&nbsp;lost 0.4%.</p>\n<p>All three major indexes remain not far off all-time highs, coming off a robust third-quarter earnings season that saw companies maintain profit margins and maintain relatively upbeat guidance.</p>\n<p>Inflation, of course, isn’t necessarily a negative for equities. Stocks are viewed as real assets, which means they tend to appreciate in an inflationary environment, making them a useful hedge against inflation pressures. Also, analysts at Quant Insights, say that stocks have grown less sensitive overall to inflation pressures since 2015.</p>\n<p>However, inflation well above the low single digits, as was the case in much of the 1970s and early 1980, has tended to coincide with lower stock-market valuations due to the negative effects of rising prices on economic growth or the Fed tightening monetary policy to bring inflation back down, Allen noted.</p>\n<p>But despite inflation running in what would appear to be the danger zone, Allen noted that real, or inflation-adjusted interest rates, haven’t risen significantly at either the short or long end of the yield curve.</p>\n<p>While the October CPI release prompted a small rise in the yield on 10-year U.S. Treasury inflation protected securities on Wednesday, the general pattern of the past six months has been characterized by falling real yields that have appeared to push U.S. equities higher, Allen said (see chart below).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/077484a8788885d4c202fb3d6a80bd17\" tg-width=\"700\" tg-height=\"498\" width=\"100%\" height=\"auto\"><span>Capital Economics</span></p>\n<p>Meanwhile, the sharp, one-day rise in the 10-year Treasury yield and moves in fed funds futures on Wednesday reflected expectations the Fed will accelerate the wind-down of its asset-buying program and begin lifting its policy interest rates in 2022 sooner and more aggressively than expected. But it didn’t indicate investors fear a long-lasting run of high inflation, said Nicholas Colas, co-founder of DataTrek Research, in a Thursday note.</p>\n<p>The market action on Wednesday “was all about investors adjusting their views on Fed policy. If [investors] really thought plus-6% inflation was the ‘new normal,’ asset prices would be much, much lower,” Colas wrote.</p>\n<p>And while the breakeven rate on five-year Treasury inflation protected securities hit a new high, they’re still signaling expectations for inflation of just 3% over the next half-decade, he said.</p>\n<p>Some investors do fear the Fed has already lost control of inflation and inflation expectations. As result, policy makers may need to tighten monetary policy much more aggressively than anticipated, potentially leading to a sharp economic downturn.</p>\n<p>But some stock-market watchers expect stocks to remain supported until policy makers show signs they’re prepared to take more aggressive action.</p>\n<p>The rise in bond yields on Wednesday marked a bounce from a sharp two-week decline that wasn’t based on fundamentals and was, therefore, unlikely to last, said Tom Essaye, founder of Sevens Report Research, in a Thursday note.</p>\n<p>“During that period, tech rallied and led markets higher, and we’re seeing both trades now unwind. And given tech’s large weighting, that will be a headwind on the S&amp;P 500,” he said.</p>\n<p>“But unless the Fed starts strongly hinting at an accelerated taper or a much- sooner-than-expected rate hike, we do not see yesterday’s hot CPI or rise in yields as a reason to get more defensive,” he said, arguing it was instead reminder of the dominant trends in the market: above-normal inflation and rising yields.</p>\n<p>A policy shift by the Fed could come before year-end, potentially spelling trouble for stocks, warned Jeremy Siegel, finance professor at the University of Pennsylvania’s Wharton School. in a CNBC interview on Wednesday.</p>\n<p>“Listen, stocks love inflation until the Fed gets serious about it and they have not been serious about it,” he said, warning that more inflation data in line with the October report before the central bank’s mid-December policy meeting would put “enormous” pressure on Chairman Jerome Powell “to come down much stronger than he has so far.”</p>\n<p>Allen said Capital Economics expects the Fed to follow through with a “modest tightening in the real stance of monetary policy,” accompanied by a grind higher for U.S. TIPS yields.</p>\n<p>“The tailwind of falling real yields turning into a modest headwind is one reason why we think U.S. equities will struggle to make gains over the next couple of years,” Allen wrote. “Another reason is that we think the recovery in the US economy will fall short of investors’ expectations.”</p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why the hottest inflation in 3 decades isn’t rattling stock-market bulls</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy the hottest inflation in 3 decades isn’t rattling stock-market bulls\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-12 15:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/why-the-hottest-inflation-in-3-decades-isnt-rattling-stock-market-bulls-11636661515?siteid=yhoof2><strong>Marketwatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stock market investors still aren’t sweating rising inflation pressures that saw U.S. consumer prices rise 6.2% year-over-year in October, a nearly 31-year high. And that might not change until the ...</p>\n\n<a href=\"https://www.marketwatch.com/story/why-the-hottest-inflation-in-3-decades-isnt-rattling-stock-market-bulls-11636661515?siteid=yhoof2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://www.marketwatch.com/story/why-the-hottest-inflation-in-3-decades-isnt-rattling-stock-market-bulls-11636661515?siteid=yhoof2","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1144158970","content_text":"Stock market investors still aren’t sweating rising inflation pressures that saw U.S. consumer prices rise 6.2% year-over-year in October, a nearly 31-year high. And that might not change until the Federal Reserve gets more aggressive, analysts said.\n“U.S. equities have shrugged off this year’s surge in inflation, probably because it has not coincided with either a rise in the real yields of Treasurys or weakness in corporate earnings,” said Oliver Allen, markets economist at Capital Economics, in a Thursday note. The real yield is the yield an investor receives after accounting for inflation.\nMarkets were briefly roiled following the October Consumer Price Index reading on Wednesday. Nominal Treasury yields rose sharply, weighing on stocks, particularly technology and other growth-oriented sectors seen as most sensitive to rising interest rates.\nEquities were stable Thursday, while the Treasury market was closed for the U.S. Veterans Day holiday. The tech-heavy Nasdaq Composite , which fell more than 1% on Wednesday, was up 0.7% Thursday, while the S&P 500 edged up 0.1% and the Dow Jones Industrial Average lost 0.4%.\nAll three major indexes remain not far off all-time highs, coming off a robust third-quarter earnings season that saw companies maintain profit margins and maintain relatively upbeat guidance.\nInflation, of course, isn’t necessarily a negative for equities. Stocks are viewed as real assets, which means they tend to appreciate in an inflationary environment, making them a useful hedge against inflation pressures. Also, analysts at Quant Insights, say that stocks have grown less sensitive overall to inflation pressures since 2015.\nHowever, inflation well above the low single digits, as was the case in much of the 1970s and early 1980, has tended to coincide with lower stock-market valuations due to the negative effects of rising prices on economic growth or the Fed tightening monetary policy to bring inflation back down, Allen noted.\nBut despite inflation running in what would appear to be the danger zone, Allen noted that real, or inflation-adjusted interest rates, haven’t risen significantly at either the short or long end of the yield curve.\nWhile the October CPI release prompted a small rise in the yield on 10-year U.S. Treasury inflation protected securities on Wednesday, the general pattern of the past six months has been characterized by falling real yields that have appeared to push U.S. equities higher, Allen said (see chart below).\nCapital Economics\nMeanwhile, the sharp, one-day rise in the 10-year Treasury yield and moves in fed funds futures on Wednesday reflected expectations the Fed will accelerate the wind-down of its asset-buying program and begin lifting its policy interest rates in 2022 sooner and more aggressively than expected. But it didn’t indicate investors fear a long-lasting run of high inflation, said Nicholas Colas, co-founder of DataTrek Research, in a Thursday note.\nThe market action on Wednesday “was all about investors adjusting their views on Fed policy. If [investors] really thought plus-6% inflation was the ‘new normal,’ asset prices would be much, much lower,” Colas wrote.\nAnd while the breakeven rate on five-year Treasury inflation protected securities hit a new high, they’re still signaling expectations for inflation of just 3% over the next half-decade, he said.\nSome investors do fear the Fed has already lost control of inflation and inflation expectations. As result, policy makers may need to tighten monetary policy much more aggressively than anticipated, potentially leading to a sharp economic downturn.\nBut some stock-market watchers expect stocks to remain supported until policy makers show signs they’re prepared to take more aggressive action.\nThe rise in bond yields on Wednesday marked a bounce from a sharp two-week decline that wasn’t based on fundamentals and was, therefore, unlikely to last, said Tom Essaye, founder of Sevens Report Research, in a Thursday note.\n“During that period, tech rallied and led markets higher, and we’re seeing both trades now unwind. And given tech’s large weighting, that will be a headwind on the S&P 500,” he said.\n“But unless the Fed starts strongly hinting at an accelerated taper or a much- sooner-than-expected rate hike, we do not see yesterday’s hot CPI or rise in yields as a reason to get more defensive,” he said, arguing it was instead reminder of the dominant trends in the market: above-normal inflation and rising yields.\nA policy shift by the Fed could come before year-end, potentially spelling trouble for stocks, warned Jeremy Siegel, finance professor at the University of Pennsylvania’s Wharton School. in a CNBC interview on Wednesday.\n“Listen, stocks love inflation until the Fed gets serious about it and they have not been serious about it,” he said, warning that more inflation data in line with the October report before the central bank’s mid-December policy meeting would put “enormous” pressure on Chairman Jerome Powell “to come down much stronger than he has so far.”\nAllen said Capital Economics expects the Fed to follow through with a “modest tightening in the real stance of monetary policy,” accompanied by a grind higher for U.S. TIPS yields.\n“The tailwind of falling real yields turning into a modest headwind is one reason why we think U.S. equities will struggle to make gains over the next couple of years,” Allen wrote. “Another reason is that we think the recovery in the US economy will fall short of investors’ expectations.”","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":745,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844730257,"gmtCreate":1636458558527,"gmtModify":1636458559007,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks!&nbsp;","listText":"Please like, thanks!&nbsp;","text":"Please like, thanks!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/844730257","repostId":"1116555756","repostType":4,"repost":{"id":"1116555756","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636455472,"share":"https://www.laohu8.com/m/news/1116555756?lang=&edition=full","pubTime":"2021-11-09 18:57","market":"us","language":"en","title":"Luminar shares soared nearly 70% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1116555756","media":"Tiger Newspress","summary":"Luminar shares soared nearly 70% in premarket trading.Luminar Technologies, Inc., the global leader ","content":"<p>Luminar&nbsp;shares&nbsp;soared&nbsp;nearly&nbsp;70%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/da9b50785fff88fb57d537950c7b5a7d\" tg-width=\"879\" tg-height=\"611\" referrerpolicy=\"no-referrer\"><a href=\"https://laohu8.com/S/LAZR\">Luminar Technologies, Inc.</a>, the global leader in automotive lidar hardware and software technology, announced today at the NVIDIA GTC conference that its lidar solution has been selected to be part of the sensor suite in the NVIDIA DRIVE Hyperion autonomous vehicle reference platform. This AI vehicle computing platform accelerates development of autonomous consumer vehicles with planned production starting in 2024.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Luminar shares soared nearly 70% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLuminar shares soared nearly 70% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-09 18:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Luminar&nbsp;shares&nbsp;soared&nbsp;nearly&nbsp;70%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/da9b50785fff88fb57d537950c7b5a7d\" tg-width=\"879\" tg-height=\"611\" referrerpolicy=\"no-referrer\"><a href=\"https://laohu8.com/S/LAZR\">Luminar Technologies, Inc.</a>, the global leader in automotive lidar hardware and software technology, announced today at the NVIDIA GTC conference that its lidar solution has been selected to be part of the sensor suite in the NVIDIA DRIVE Hyperion autonomous vehicle reference platform. This AI vehicle computing platform accelerates development of autonomous consumer vehicles with planned production starting in 2024.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LAZR":"Luminar Technologies, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116555756","content_text":"Luminar shares soared nearly 70% in premarket trading.Luminar Technologies, Inc., the global leader in automotive lidar hardware and software technology, announced today at the NVIDIA GTC conference that its lidar solution has been selected to be part of the sensor suite in the NVIDIA DRIVE Hyperion autonomous vehicle reference platform. This AI vehicle computing platform accelerates development of autonomous consumer vehicles with planned production starting in 2024.","news_type":1,"symbols_score_info":{"LAZR":0.9}},"isVote":1,"tweetType":1,"viewCount":491,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":848459419,"gmtCreate":1636022326389,"gmtModify":1636022326796,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks!","listText":"Please like, thanks!","text":"Please like, thanks!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848459419","repostId":"1189037300","repostType":4,"isVote":1,"tweetType":1,"viewCount":648,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":841796180,"gmtCreate":1635941063632,"gmtModify":1635941063988,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks&nbsp;","listText":"Please like, thanks&nbsp;","text":"Please like, thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/841796180","repostId":"843769633","repostType":1,"repost":{"id":843769633,"gmtCreate":1635859540520,"gmtModify":1635899583189,"author":{"id":"3527667590215376","authorId":"3527667590215376","name":"期权小班长","avatar":"https://static.tigerbbs.com/e785bea87af8baf08d2b24111b78c16a","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3527667590215376","authorIdStr":"3527667590215376"},"themes":[],"title":"电动车走势不理想？推荐一种舒适的赚钱方法","htmlText":"第二部分照例是本周财报期权异动股分享。 特斯拉依然是最适合卖put的标的，不过昨天推荐的利润比较低了，可以考虑下周put，并适当下调行权价。 今日卖put： 标的代码 到期日 行权价 权利金 隐含波动率 年化收益% NIO 2021/11/12 35 0.3 75% 27% LI 2021/11/12 28 0.18 64% 20% XPEV 2021/11/12 41 0.24 67% 18% 本周曾推荐 仅做跟踪记录 <a target=\"_blank\" href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a> 2021/11/5 950 2.84 138% —————— <a target=\"_blank\" href=\"https://laohu8.com/S/BABA\">$阿里巴巴(BABA)$</a> 2021/11/12 140 0.28 63% —————— <a target=\"_blank\" href=\"https://laohu8.com/S/JD\">$京东(JD)$</a> 2021/11/5 72 0.05 61% —————— HK03690 2021/11/29 235 3.7 57% —————— <a target=\"_blank\" href=\"https://laohu8.com/S/NIO\">$蔚来(NIO)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/LI\">$理想汽车(LI)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/XPEV\">$小鹏汽车(XPEV)$</a> 电车三兄弟齐上榜，选想做的那只。这两天公布10月汽车交付数据，小鹏最好，理想次之，蔚来垫底，据称蔚来被拖累的原因是生产","listText":"第二部分照例是本周财报期权异动股分享。 特斯拉依然是最适合卖put的标的，不过昨天推荐的利润比较低了，可以考虑下周put，并适当下调行权价。 今日卖put： 标的代码 到期日 行权价 权利金 隐含波动率 年化收益% NIO 2021/11/12 35 0.3 75% 27% LI 2021/11/12 28 0.18 64% 20% XPEV 2021/11/12 41 0.24 67% 18% 本周曾推荐 仅做跟踪记录 <a target=\"_blank\" href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a> 2021/11/5 950 2.84 138% —————— <a target=\"_blank\" href=\"https://laohu8.com/S/BABA\">$阿里巴巴(BABA)$</a> 2021/11/12 140 0.28 63% —————— <a target=\"_blank\" href=\"https://laohu8.com/S/JD\">$京东(JD)$</a> 2021/11/5 72 0.05 61% —————— HK03690 2021/11/29 235 3.7 57% —————— <a target=\"_blank\" href=\"https://laohu8.com/S/NIO\">$蔚来(NIO)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/LI\">$理想汽车(LI)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/XPEV\">$小鹏汽车(XPEV)$</a> 电车三兄弟齐上榜，选想做的那只。这两天公布10月汽车交付数据，小鹏最好，理想次之，蔚来垫底，据称蔚来被拖累的原因是生产","text":"第二部分照例是本周财报期权异动股分享。 特斯拉依然是最适合卖put的标的，不过昨天推荐的利润比较低了，可以考虑下周put，并适当下调行权价。 今日卖put： 标的代码 到期日 行权价 权利金 隐含波动率 年化收益% NIO 2021/11/12 35 0.3 75% 27% LI 2021/11/12 28 0.18 64% 20% XPEV 2021/11/12 41 0.24 67% 18% 本周曾推荐 仅做跟踪记录 $特斯拉(TSLA)$ 2021/11/5 950 2.84 138% —————— $阿里巴巴(BABA)$ 2021/11/12 140 0.28 63% —————— $京东(JD)$ 2021/11/5 72 0.05 61% —————— HK03690 2021/11/29 235 3.7 57% —————— $蔚来(NIO)$ $理想汽车(LI)$ $小鹏汽车(XPEV)$ 电车三兄弟齐上榜，选想做的那只。这两天公布10月汽车交付数据，小鹏最好，理想次之，蔚来垫底，据称蔚来被拖累的原因是生产","images":[{"img":"https://static.tigerbbs.com/e97760c6db03b503878eac6cb4af51e8","width":"1079","height":"1126"},{"img":"https://static.tigerbbs.com/6f2c66c187e069e2953b2e127fb1ef51","width":"1079","height":"1098"},{"img":"https://static.tigerbbs.com/ef94afcbb061b35d3955530440a2dd91","width":"1079","height":"1090"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/843769633","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":3,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":581,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":857009341,"gmtCreate":1635489924549,"gmtModify":1635489924947,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thank you","listText":"Please like, thank you","text":"Please like, thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/857009341","repostId":"1122237204","repostType":4,"isVote":1,"tweetType":1,"viewCount":549,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":852917557,"gmtCreate":1635234758821,"gmtModify":1635234759171,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks!","listText":"Please like, thanks!","text":"Please like, thanks!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/852917557","repostId":"2177412181","repostType":4,"repost":{"id":"2177412181","kind":"highlight","pubTimestamp":1635219132,"share":"https://www.laohu8.com/m/news/2177412181?lang=&edition=full","pubTime":"2021-10-26 11:32","market":"us","language":"en","title":"AMD earnings look to again succeed where Intel disappointed","url":"https://stock-news.laohu8.com/highlight/detail?id=2177412181","media":"MarketWatch","summary":"AMD earnings preview: After showing data-center gains as Intel declined two quarters in a row, analy","content":"<p>AMD earnings preview: After showing data-center gains as Intel declined two quarters in a row, analysts now point to AMD's growing margins as Intel's are projected to shrink</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/30ec3c9220844c561016f0de86f86f52\" tg-width=\"699\" tg-height=\"394\" referrerpolicy=\"no-referrer\"><span>Advanced Micro Devices Inc.’s growing series of Epyc server chips has been the talk of Wall Street in recent quarters, but that may switch to gross margins in this quarter’s earnings report.</span></p>\n<p>Advanced Micro Devices Inc. is set to follow yet another rough earnings report from Intel Corp., and once again could show gains in an area that caused pain for its larger rival.</p>\n<p>AMD&nbsp;is scheduled to report third-quarter earnings on Tuesday after the close of markets, after Intel&nbsp;reported an earnings beat Thursday that hardly mattered as revenue came in light. More important to analysts was Intel's forecast for declining margins over the next few years as its chief executive doubles down on new manufacturing capacity to try to retake its former glory as the undisputed chip leader.</p>\n<p>That led to downgrades on Friday and Intel's worst one-day performance since the chip leader said it was going to delay its next generation of chips, an announcement that had fired up even more investor support for AMD back then.</p>\n<p>Bernstein analyst Stacy Rasgon, who has a market perform rating on AMD and a $110 price target, said AMD will continue to benefit from Intel's transition, and called attention to an AMD metric that was one of enormous concern during Intel's call: Gross margins.</p>\n<p>\"We believe Street gross margin estimates appear unaggressive going forward (which is not something we have typically said for AMD), and the company is now (for the first time ever) starting to return cash,\" Rasgon said.</p>\n<p>That underscores another show of how Intel and AMD are transitioning with respect to one another: Analysts on the Intel call were very concerned that Intel's margins were falling despite company assurances they would stay just above 50% for the next few years. Meanwhile, AMD gross margins have been rising, and are likely to break above 50%, if not in this earnings report, then sometime soon. Three months ago, AMD reported gross margins of 48%, up from 44% in the previous year.</p>\n<p>While AMD is referred to as Intel's \"smaller rival,\" that gap has been steadily closing for a while now. At Friday's close, AMD had a market cap of $145.34 billion, or nearly 73% of Intel's $200.66 billion. Just this past summer, AMD's $111.5 billion valuation was a little more than half Intel's $219.5 billion cap.</p>\n<p>One other are to look at will be data-center sales, as finally swung to a gain in that important segment in the quarter. Over the past two quarters, Intel has posted significant year-over-year declines in the increasingly important category, while AMD has more than doubled its sales. That raises the question whether Intel clawed back some market share, or whether data-center sales were just generally better all around, which AMD's report could answer.</p>\n<p><b>What to expect</b></p>\n<p><b>Earnings: </b>Of the 34 analysts surveyed by FactSet, AMD on average is expected to post adjusted earnings of 66 cents a share, up from 41 cents a share reported in the year-ago period. Estimize, a software platform that crowdsources estimates from hedge-fund executives, brokerages, buy-side analysts and others, calls for earnings of 72 cents a share.</p>\n<p><b>Revenue:</b> Of the 32 analysts polled by FactSet, AMD, on average, is expected to post revenue of $4.11 billion, up from the $2.8 billion reported in the year-ago quarter. AMD had forecast $4 billion to $4.2 billion. Estimize expects revenue of $4.22 billion.</p>\n<p><b>Stock movement:</b> While AMD earnings and sales have both topped Wall Street estimates over the past five quarterly reports, but shares only gained the next day twice, about three months ago and when the stock popped nearly 13% five quarters ago.</p>\n<p>AMD shares rose 9.6% in the third quarter. In contrast, the PHLX Semiconductor Index declined 2.6%, the S&amp;P 500 index rose 0.2%, and the tech-heavy Nasdaq Composite Index declined 0.4%. On Friday, the day after Intel's report, AMD shares closed at a record high of $119.82.</p>\n<p><b>What analysts are saying</b></p>\n<p>Cowen analyst Matthew Ramsay, who has an outperform rating and a $120 price target on AMD, said he's \"lookin' for more of the same.\"</p>\n<p>\"We continue to monitor the PC market for signs of demand slowing or supply improving,\" Ramsay said. \"Near-term, we see resilient demand outside Chromebooks, but prefer a prudent/agnostic view on 2022 like AMD took on its last call.\"</p>\n<p>Earlier in the month, research firms released data showing that pandemic-fueled growth in PC shipments had slowed considerably as the world not only wrestles with a chip shortage but overall supply-chain issues.</p>\n<p>On data-center sales, Ramsay is even more optimistic estimating that segment will account for more than 25% of sales compared with less than 20% a year ago.</p>\n<p>\"We believe datacenter passing a quarter of AMD's business could draw investor attention,\" Ramsay said. \"We remind investors that the most important business for AMD remains datacenter, which we estimate doubled in 2020, with CEO Lisa Su noting she sees the business momentum accelerating in 2021.\"</p>\n<p>Susquehanna Financial analyst Christopher Rolland, who has a positive rating and a $130 price target on AMD, said he expects another solid quarter driven by enterprise and server sales, but that \"given the slowing PC market, we do not expect mgmt to raise their FY top-line guidance as they have done in numerous updates over the last year.\"</p>\n<p>Still, Rolland expects AMD to report share gains from Intel in both desktop and laptop PCs as well as enterprise and gaming PCs.</p>\n<p>Of the 39 analysts who cover AMD, 23 have buy or overweight ratings, and 16 have hold ratings, with an average price target of $117.55.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AMD earnings look to again succeed where Intel disappointed</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAMD earnings look to again succeed where Intel disappointed\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-26 11:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/amd-earnings-look-to-again-succeed-where-intel-disappointed-11634942264?mod=mw_quote_news><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AMD earnings preview: After showing data-center gains as Intel declined two quarters in a row, analysts now point to AMD's growing margins as Intel's are projected to shrink\nAdvanced Micro Devices Inc...</p>\n\n<a href=\"https://www.marketwatch.com/story/amd-earnings-look-to-again-succeed-where-intel-disappointed-11634942264?mod=mw_quote_news\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMD":"美国超微公司"},"source_url":"https://www.marketwatch.com/story/amd-earnings-look-to-again-succeed-where-intel-disappointed-11634942264?mod=mw_quote_news","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2177412181","content_text":"AMD earnings preview: After showing data-center gains as Intel declined two quarters in a row, analysts now point to AMD's growing margins as Intel's are projected to shrink\nAdvanced Micro Devices Inc.’s growing series of Epyc server chips has been the talk of Wall Street in recent quarters, but that may switch to gross margins in this quarter’s earnings report.\nAdvanced Micro Devices Inc. is set to follow yet another rough earnings report from Intel Corp., and once again could show gains in an area that caused pain for its larger rival.\nAMD is scheduled to report third-quarter earnings on Tuesday after the close of markets, after Intel reported an earnings beat Thursday that hardly mattered as revenue came in light. More important to analysts was Intel's forecast for declining margins over the next few years as its chief executive doubles down on new manufacturing capacity to try to retake its former glory as the undisputed chip leader.\nThat led to downgrades on Friday and Intel's worst one-day performance since the chip leader said it was going to delay its next generation of chips, an announcement that had fired up even more investor support for AMD back then.\nBernstein analyst Stacy Rasgon, who has a market perform rating on AMD and a $110 price target, said AMD will continue to benefit from Intel's transition, and called attention to an AMD metric that was one of enormous concern during Intel's call: Gross margins.\n\"We believe Street gross margin estimates appear unaggressive going forward (which is not something we have typically said for AMD), and the company is now (for the first time ever) starting to return cash,\" Rasgon said.\nThat underscores another show of how Intel and AMD are transitioning with respect to one another: Analysts on the Intel call were very concerned that Intel's margins were falling despite company assurances they would stay just above 50% for the next few years. Meanwhile, AMD gross margins have been rising, and are likely to break above 50%, if not in this earnings report, then sometime soon. Three months ago, AMD reported gross margins of 48%, up from 44% in the previous year.\nWhile AMD is referred to as Intel's \"smaller rival,\" that gap has been steadily closing for a while now. At Friday's close, AMD had a market cap of $145.34 billion, or nearly 73% of Intel's $200.66 billion. Just this past summer, AMD's $111.5 billion valuation was a little more than half Intel's $219.5 billion cap.\nOne other are to look at will be data-center sales, as finally swung to a gain in that important segment in the quarter. Over the past two quarters, Intel has posted significant year-over-year declines in the increasingly important category, while AMD has more than doubled its sales. That raises the question whether Intel clawed back some market share, or whether data-center sales were just generally better all around, which AMD's report could answer.\nWhat to expect\nEarnings: Of the 34 analysts surveyed by FactSet, AMD on average is expected to post adjusted earnings of 66 cents a share, up from 41 cents a share reported in the year-ago period. Estimize, a software platform that crowdsources estimates from hedge-fund executives, brokerages, buy-side analysts and others, calls for earnings of 72 cents a share.\nRevenue: Of the 32 analysts polled by FactSet, AMD, on average, is expected to post revenue of $4.11 billion, up from the $2.8 billion reported in the year-ago quarter. AMD had forecast $4 billion to $4.2 billion. Estimize expects revenue of $4.22 billion.\nStock movement: While AMD earnings and sales have both topped Wall Street estimates over the past five quarterly reports, but shares only gained the next day twice, about three months ago and when the stock popped nearly 13% five quarters ago.\nAMD shares rose 9.6% in the third quarter. In contrast, the PHLX Semiconductor Index declined 2.6%, the S&P 500 index rose 0.2%, and the tech-heavy Nasdaq Composite Index declined 0.4%. On Friday, the day after Intel's report, AMD shares closed at a record high of $119.82.\nWhat analysts are saying\nCowen analyst Matthew Ramsay, who has an outperform rating and a $120 price target on AMD, said he's \"lookin' for more of the same.\"\n\"We continue to monitor the PC market for signs of demand slowing or supply improving,\" Ramsay said. \"Near-term, we see resilient demand outside Chromebooks, but prefer a prudent/agnostic view on 2022 like AMD took on its last call.\"\nEarlier in the month, research firms released data showing that pandemic-fueled growth in PC shipments had slowed considerably as the world not only wrestles with a chip shortage but overall supply-chain issues.\nOn data-center sales, Ramsay is even more optimistic estimating that segment will account for more than 25% of sales compared with less than 20% a year ago.\n\"We believe datacenter passing a quarter of AMD's business could draw investor attention,\" Ramsay said. \"We remind investors that the most important business for AMD remains datacenter, which we estimate doubled in 2020, with CEO Lisa Su noting she sees the business momentum accelerating in 2021.\"\nSusquehanna Financial analyst Christopher Rolland, who has a positive rating and a $130 price target on AMD, said he expects another solid quarter driven by enterprise and server sales, but that \"given the slowing PC market, we do not expect mgmt to raise their FY top-line guidance as they have done in numerous updates over the last year.\"\nStill, Rolland expects AMD to report share gains from Intel in both desktop and laptop PCs as well as enterprise and gaming PCs.\nOf the 39 analysts who cover AMD, 23 have buy or overweight ratings, and 16 have hold ratings, with an average price target of $117.55.","news_type":1,"symbols_score_info":{"AMD":0.9}},"isVote":1,"tweetType":1,"viewCount":519,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":858407067,"gmtCreate":1635109734193,"gmtModify":1635109734585,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks","listText":"Please like, thanks","text":"Please like, thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/858407067","repostId":"1174514229","repostType":4,"repost":{"id":"1174514229","kind":"news","pubTimestamp":1635035471,"share":"https://www.laohu8.com/m/news/1174514229?lang=&edition=full","pubTime":"2021-10-24 08:31","market":"us","language":"en","title":"US IPO Week Ahead: Semiconductors, energy storage, designer apparel, and more in a 12 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1174514229","media":"Renaissance Capital","summary":"The IPO market continues to stay busy with 12 IPOs schedule to raise $6.8 billion in the week ahead.","content":"<p>The IPO market continues to stay busy with 12 IPOs schedule to raise $6.8 billion in the week ahead.</p>\n<p>Semiconductor foundry&nbsp;<b>GlobalFoundries</b>(GFS) plans to raise $2.4 billion at a $24.6 billion market cap. Backed by Abu Dhabi’s Mubadala, US-based GlobalFoundries is one of the world’s leading specialty semiconductor foundries. Unprofitable with lumpy growth, the company states that it is the only scaled pure-play foundry with a global footprint that is not based in China.</p>\n<p>Enterprise cloud data management platform&nbsp;<b>Informatica</b>(INFA) plans to raise $885 million at an $8.7 billion market cap. This company provides data integration services on its AI-powered platform to over 5,700 customers through both licenses and subscriptions. Although it will be highly leveraged post-IPO, Informatica is a recognized leader in the global data management market and saw strong subscription ARR growth in the 1H21.</p>\n<p>Energy storage provider&nbsp;<b>Fluence Energy</b>(FLNC) plans to raise $698 million at a $3.8 billion market cap. Formed by Siemens and AES, this company sells energy storage products and services to utilities, independent power producers, project developers, and commercial and industrial customers. Fast growing but unprofitable, Fluence Energy deployed 942 MW of storage products as of 6/30/21.</p>\n<p>Revenue cycle management platform&nbsp;<b>Ensemble Health Partners</b>(ENSB) plans to raise $605 million at a $3.6 billion market cap. This platform provides revenue cycle management solutions to the healthcare industry. Profitable with accelerating growth in the 1H21, Ensemble Health has over $20 billion in annual client net patient revenue under management.</p>\n<p>Hiring solutions provider&nbsp;<b>HireRight Holdings</b>(HRT) plans to raise $500 million at a $1.8 billion market cap. This company provides background checks, verification, identification, monitoring, and drug and health screening services to over 40,000 customers. HireRight was profitable on an EBIT basis in the 1H21, though cash flow swung negative.</p>\n<p>Online education marketplace&nbsp;<b>Udemy</b>(UDMY) plans to raise $406 million at a $4.3 billion market cap. This education platform provides over 183,000 courses in 75 languages to over 44 million customers in over 180 countries. Growing but unprofitable, Udemy has registered more than 73 million users since its inception.</p>\n<p>Chinese drug in-licensor&nbsp;<b>LianBio</b>(LIAN) plans to raise $325 million at a $1.8 billion market cap. Focused on China and other Asian markets, this biopharmaceutical company develops and commercializes drugs for a variety of indications. LianBio’s pipeline currently consists of nine product candidates across five different therapeutics areas.</p>\n<p><b>Rent the Runway</b>(RENT) plans to raise $293 million at a $1.4 billion market cap. This apparel rental company originally focused on a-la-carte rentals of dresses for events, but has gradually transitioned to mostly generating revenue from monthly subscription boxes. While the company has seen active subscribers and revenue rebound in the last two quarters, it is unprofitable and leveraged post-IPO.</p>\n<p>Aesthetic medical device maker&nbsp;<b>Candela Medical</b>(CDLA) plans to raise $250 million at a $1.7 billion market cap. Selling products directly in 18 countries and indirectly in 66 countries, this company develops medical devices for elective aesthetic procedures. Despite being hard hit by the pandemic, Candela Medical saw strong growth and turned profitable in the 1H21.</p>\n<p>Fire pit brand&nbsp;<b>Solo Brands</b>(DTC) plans to raise $200 million at a $1.5 billion market cap. Solo Brands sells fire pits, camp stoves, and other outdoor gear through its DTC platform. Fast growing and profitable, this outdoor e-commerce has an installed base of more than 2.3 million customers.</p>\n<p>Body contouring provider&nbsp;<b>AirSculpt Technologies</b>(AIRS) plans to raise $160 million at an $886 million market cap. This company provides minimally-invasive body contouring procedures through 16 centers across 13 states in the US. AirSculpt Technologies is profitable with solid growth, and has seen an increase in same-center case volume as a result of lessening effects of COVID-19.</p>\n<p>Technology firm&nbsp;<b>Arteris</b>(AIP) plans to raise $75 million at a $555 million market cap. This technology company develops and licenses interconnect intellectual property that manages the on-chip communications in System-on-Chip semiconductor devices. Arteris is unprofitable but saw growth accelerate in the 1H21.</p>\n<p><img src=\"https://static.tigerbbs.com/99c3b0173e59f4e69ff484c12bd137e7\" tg-width=\"1270\" tg-height=\"704\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/64e34b3c49a856e99ba64a2d57410844\" tg-width=\"1272\" tg-height=\"582\" referrerpolicy=\"no-referrer\"></p>\n<p>Street research is expected for six companies, and lock-up periods will be expiring for up to 12 companies.</p>\n<p><b>IPO Market Snapshot</b></p>\n<p>The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 10/22/21, the Renaissance IPO Index was up 8.2% year-to-date, while the S&amp;P 500 was up 21.1%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Uber Technologies (UBER) and Moderna (MRNA). The Renaissance International IPO Index was down 15.8% year-to-date, while the ACWX was up 9.1%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.</p>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: Semiconductors, energy storage, designer apparel, and more in a 12 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: Semiconductors, energy storage, designer apparel, and more in a 12 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-24 08:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/87676/US-IPO-Week-Ahead-Semiconductors-energy-storage-designer-apparel-and-more-i><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The IPO market continues to stay busy with 12 IPOs schedule to raise $6.8 billion in the week ahead.\nSemiconductor foundry GlobalFoundries(GFS) plans to raise $2.4 billion at a $24.6 billion market ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/87676/US-IPO-Week-Ahead-Semiconductors-energy-storage-designer-apparel-and-more-i\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","INFA":"Informatica Inc.","UDMY":"Udemy, Inc.","RENT":"Rent the Runway, Inc.","GFS":"GLOBALFOUNDRIES Inc.",".IXIC":"NASDAQ Composite",".DJI":"道琼斯","FLNC":"Fluence Energy, Inc.","HRT":"HireRight Holdings Corp.","AIP":"Arteris, Inc.","AIRS":"Airsculpt Technologies"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/87676/US-IPO-Week-Ahead-Semiconductors-energy-storage-designer-apparel-and-more-i","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1174514229","content_text":"The IPO market continues to stay busy with 12 IPOs schedule to raise $6.8 billion in the week ahead.\nSemiconductor foundry GlobalFoundries(GFS) plans to raise $2.4 billion at a $24.6 billion market cap. Backed by Abu Dhabi’s Mubadala, US-based GlobalFoundries is one of the world’s leading specialty semiconductor foundries. Unprofitable with lumpy growth, the company states that it is the only scaled pure-play foundry with a global footprint that is not based in China.\nEnterprise cloud data management platform Informatica(INFA) plans to raise $885 million at an $8.7 billion market cap. This company provides data integration services on its AI-powered platform to over 5,700 customers through both licenses and subscriptions. Although it will be highly leveraged post-IPO, Informatica is a recognized leader in the global data management market and saw strong subscription ARR growth in the 1H21.\nEnergy storage provider Fluence Energy(FLNC) plans to raise $698 million at a $3.8 billion market cap. Formed by Siemens and AES, this company sells energy storage products and services to utilities, independent power producers, project developers, and commercial and industrial customers. Fast growing but unprofitable, Fluence Energy deployed 942 MW of storage products as of 6/30/21.\nRevenue cycle management platform Ensemble Health Partners(ENSB) plans to raise $605 million at a $3.6 billion market cap. This platform provides revenue cycle management solutions to the healthcare industry. Profitable with accelerating growth in the 1H21, Ensemble Health has over $20 billion in annual client net patient revenue under management.\nHiring solutions provider HireRight Holdings(HRT) plans to raise $500 million at a $1.8 billion market cap. This company provides background checks, verification, identification, monitoring, and drug and health screening services to over 40,000 customers. HireRight was profitable on an EBIT basis in the 1H21, though cash flow swung negative.\nOnline education marketplace Udemy(UDMY) plans to raise $406 million at a $4.3 billion market cap. This education platform provides over 183,000 courses in 75 languages to over 44 million customers in over 180 countries. Growing but unprofitable, Udemy has registered more than 73 million users since its inception.\nChinese drug in-licensor LianBio(LIAN) plans to raise $325 million at a $1.8 billion market cap. Focused on China and other Asian markets, this biopharmaceutical company develops and commercializes drugs for a variety of indications. LianBio’s pipeline currently consists of nine product candidates across five different therapeutics areas.\nRent the Runway(RENT) plans to raise $293 million at a $1.4 billion market cap. This apparel rental company originally focused on a-la-carte rentals of dresses for events, but has gradually transitioned to mostly generating revenue from monthly subscription boxes. While the company has seen active subscribers and revenue rebound in the last two quarters, it is unprofitable and leveraged post-IPO.\nAesthetic medical device maker Candela Medical(CDLA) plans to raise $250 million at a $1.7 billion market cap. Selling products directly in 18 countries and indirectly in 66 countries, this company develops medical devices for elective aesthetic procedures. Despite being hard hit by the pandemic, Candela Medical saw strong growth and turned profitable in the 1H21.\nFire pit brand Solo Brands(DTC) plans to raise $200 million at a $1.5 billion market cap. Solo Brands sells fire pits, camp stoves, and other outdoor gear through its DTC platform. Fast growing and profitable, this outdoor e-commerce has an installed base of more than 2.3 million customers.\nBody contouring provider AirSculpt Technologies(AIRS) plans to raise $160 million at an $886 million market cap. This company provides minimally-invasive body contouring procedures through 16 centers across 13 states in the US. AirSculpt Technologies is profitable with solid growth, and has seen an increase in same-center case volume as a result of lessening effects of COVID-19.\nTechnology firm Arteris(AIP) plans to raise $75 million at a $555 million market cap. This technology company develops and licenses interconnect intellectual property that manages the on-chip communications in System-on-Chip semiconductor devices. Arteris is unprofitable but saw growth accelerate in the 1H21.\n\nStreet research is expected for six companies, and lock-up periods will be expiring for up to 12 companies.\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 10/22/21, the Renaissance IPO Index was up 8.2% year-to-date, while the S&P 500 was up 21.1%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Uber Technologies (UBER) and Moderna (MRNA). The Renaissance International IPO Index was down 15.8% year-to-date, while the ACWX was up 9.1%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"AIP":0.9,"AIRS":0.9,"CDLA":0.9,"DTC":0.9,"ENSB":0.9,"FLNC":0.9,"GFS":0.9,"HRT":0.9,"INFA":0.9,"LIAN":0.9,"RENT":0.9,"UDMY":0.9}},"isVote":1,"tweetType":1,"viewCount":540,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":853278358,"gmtCreate":1634820641511,"gmtModify":1634820641924,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks!","listText":"Please like, thanks!","text":"Please like, thanks!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/853278358","repostId":"2177468666","repostType":4,"repost":{"id":"2177468666","kind":"highlight","pubTimestamp":1634819400,"share":"https://www.laohu8.com/m/news/2177468666?lang=&edition=full","pubTime":"2021-10-21 20:30","market":"us","language":"en","title":"Weekly jobless claims fall to fresh pandemic-era low of 290,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2177468666","media":"Yahoo","summary":"New weekly jobless claims held below 300,000 for a back-to-back week as labor market conditions trud","content":"<p>New weekly jobless claims held below 300,000 for a back-to-back week as labor market conditions trudged back toward pre-pandemic levels.</p>\n<p>TheLabor Department released its jobless claimsreport Thursday morning. Here were the main metrics from the print, compared to consensus estimates compiled by Bloomberg:</p>\n<ul>\n <li><b>Initial unemployment claims, week ended October 16:</b>&nbsp;290,000 vs.297,000 expected and a revised296,000 during prior week</li>\n <li><b>Continuing claims, week ended October 9:</b>&nbsp;2.481 millionvs.2.548 million expected and a revised 2.603 million during prior week</li>\n</ul>\n<p>Last week's initial unemployment claims fell by a greater-than-expected margin, bringing the number of new filings back to the lowest level since March 2020. The four-week moving average for new jobless claims also dropped by 15,250 to reach 319,750 as of last week, also marking the least since March of last year.</p>\n<p>The latest claims data reflects a labor market that has made considerable progress in reducing separations since its pandemic-era peak. However, it also still has a ways to go before returning entirely to pre-virus trends. In October 2020, new filings were coming in at a weekly rate of over 700,000, but in the same month in 2019, initial claims averaged just over 210,000.</p>\n<p><img src=\"https://static.tigerbbs.com/037a3eb5ac51386ced727a2f28beb4e3\" tg-width=\"640\" tg-height=\"563\" width=\"100%\" height=\"auto\"></p>\n<p>The steady move lower in first-time filers so far this year has coincided with a jump in demand for labor and a reluctance by employers to release those already on their payrolls amid worker scarcities.</p>\n<p>But many workers have also been departing their roles of their own volition. A record 4.3 million people quit their jobs in the U.S. in. August, based on the Labor Department's most recent data. And job openings overall were at a record high of more than 10.4 million as of the end of the summer.</p>\n<p>\"While mass layoffs have been avoided of late, helping jobless claims to decline, many who are employed feel some combination of empowerment, restlessness and/or exhaustion. This is borne out in the record number of workers quitting their jobs and strikes among union members popping up around the nation,\" Mark Hamrick, Bankrate senior economic analyst, wrote in an email on Tuesday.</p>\n<p>\"Making matters worse, inflation is eroding wage gains for some, fueling desire to find new employment with better pay, working conditions and flexibility,\" he added.</p>\n<p>Continuing jobless claims, capturing the number of individuals still claiming benefits via regular state programs, also reached a fresh pandemic-era low of 2.481 million as of early October. The insured unemployment rate, or the ratio of people on unemployment benefits divided by the overall force, dipped by 0.1 percentage points to reach 1.8% for the week ended Oct. 9.</p>\n<p></p>","source":"lsy1584348713084","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Weekly jobless claims fall to fresh pandemic-era low of 290,000</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWeekly jobless claims fall to fresh pandemic-era low of 290,000\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-21 20:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/weekly-jobless-claims-week-ended-october-16-2021-193313259.html><strong>Yahoo</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>New weekly jobless claims held below 300,000 for a back-to-back week as labor market conditions trudged back toward pre-pandemic levels.\nTheLabor Department released its jobless claimsreport Thursday ...</p>\n\n<a href=\"https://finance.yahoo.com/news/weekly-jobless-claims-week-ended-october-16-2021-193313259.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FWRG":"First Watch Restaurant Group, Inc.","TERN":"Terns Pharmaceuticals, Inc.","CRCT":"Cricut, Inc.","OLPX":"Olaplex Holdings, Inc.","HCTI":"Healthcare Triangle, Inc."},"source_url":"https://finance.yahoo.com/news/weekly-jobless-claims-week-ended-october-16-2021-193313259.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2177468666","content_text":"New weekly jobless claims held below 300,000 for a back-to-back week as labor market conditions trudged back toward pre-pandemic levels.\nTheLabor Department released its jobless claimsreport Thursday morning. Here were the main metrics from the print, compared to consensus estimates compiled by Bloomberg:\n\nInitial unemployment claims, week ended October 16: 290,000 vs.297,000 expected and a revised296,000 during prior week\nContinuing claims, week ended October 9: 2.481 millionvs.2.548 million expected and a revised 2.603 million during prior week\n\nLast week's initial unemployment claims fell by a greater-than-expected margin, bringing the number of new filings back to the lowest level since March 2020. The four-week moving average for new jobless claims also dropped by 15,250 to reach 319,750 as of last week, also marking the least since March of last year.\nThe latest claims data reflects a labor market that has made considerable progress in reducing separations since its pandemic-era peak. However, it also still has a ways to go before returning entirely to pre-virus trends. In October 2020, new filings were coming in at a weekly rate of over 700,000, but in the same month in 2019, initial claims averaged just over 210,000.\n\nThe steady move lower in first-time filers so far this year has coincided with a jump in demand for labor and a reluctance by employers to release those already on their payrolls amid worker scarcities.\nBut many workers have also been departing their roles of their own volition. A record 4.3 million people quit their jobs in the U.S. in. August, based on the Labor Department's most recent data. And job openings overall were at a record high of more than 10.4 million as of the end of the summer.\n\"While mass layoffs have been avoided of late, helping jobless claims to decline, many who are employed feel some combination of empowerment, restlessness and/or exhaustion. This is borne out in the record number of workers quitting their jobs and strikes among union members popping up around the nation,\" Mark Hamrick, Bankrate senior economic analyst, wrote in an email on Tuesday.\n\"Making matters worse, inflation is eroding wage gains for some, fueling desire to find new employment with better pay, working conditions and flexibility,\" he added.\nContinuing jobless claims, capturing the number of individuals still claiming benefits via regular state programs, also reached a fresh pandemic-era low of 2.481 million as of early October. The insured unemployment rate, or the ratio of people on unemployment benefits divided by the overall force, dipped by 0.1 percentage points to reach 1.8% for the week ended Oct. 9.","news_type":1,"symbols_score_info":{"ALVU":0.9,"CRCT":0.9,"END":0.9,"FWRG":0.9,"HCTI":0.9,"OLPX":0.9,"TERN":0.9}},"isVote":1,"tweetType":1,"viewCount":495,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":812631531,"gmtCreate":1630580798523,"gmtModify":1631888728647,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Like my comment, thanks!","listText":"Like my comment, thanks!","text":"Like my comment, thanks!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/812631531","repostId":"1159580926","repostType":4,"isVote":1,"tweetType":1,"viewCount":674,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819524958,"gmtCreate":1630079022074,"gmtModify":1704955718373,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like&nbsp;","listText":"Please like&nbsp;","text":"Please like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/819524958","repostId":"1184815007","repostType":4,"isVote":1,"tweetType":1,"viewCount":377,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":858407067,"gmtCreate":1635109734193,"gmtModify":1635109734585,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks","listText":"Please like, thanks","text":"Please like, thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/858407067","repostId":"1174514229","repostType":4,"repost":{"id":"1174514229","kind":"news","pubTimestamp":1635035471,"share":"https://www.laohu8.com/m/news/1174514229?lang=&edition=full","pubTime":"2021-10-24 08:31","market":"us","language":"en","title":"US IPO Week Ahead: Semiconductors, energy storage, designer apparel, and more in a 12 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1174514229","media":"Renaissance Capital","summary":"The IPO market continues to stay busy with 12 IPOs schedule to raise $6.8 billion in the week ahead.","content":"<p>The IPO market continues to stay busy with 12 IPOs schedule to raise $6.8 billion in the week ahead.</p>\n<p>Semiconductor foundry&nbsp;<b>GlobalFoundries</b>(GFS) plans to raise $2.4 billion at a $24.6 billion market cap. Backed by Abu Dhabi’s Mubadala, US-based GlobalFoundries is one of the world’s leading specialty semiconductor foundries. Unprofitable with lumpy growth, the company states that it is the only scaled pure-play foundry with a global footprint that is not based in China.</p>\n<p>Enterprise cloud data management platform&nbsp;<b>Informatica</b>(INFA) plans to raise $885 million at an $8.7 billion market cap. This company provides data integration services on its AI-powered platform to over 5,700 customers through both licenses and subscriptions. Although it will be highly leveraged post-IPO, Informatica is a recognized leader in the global data management market and saw strong subscription ARR growth in the 1H21.</p>\n<p>Energy storage provider&nbsp;<b>Fluence Energy</b>(FLNC) plans to raise $698 million at a $3.8 billion market cap. Formed by Siemens and AES, this company sells energy storage products and services to utilities, independent power producers, project developers, and commercial and industrial customers. Fast growing but unprofitable, Fluence Energy deployed 942 MW of storage products as of 6/30/21.</p>\n<p>Revenue cycle management platform&nbsp;<b>Ensemble Health Partners</b>(ENSB) plans to raise $605 million at a $3.6 billion market cap. This platform provides revenue cycle management solutions to the healthcare industry. Profitable with accelerating growth in the 1H21, Ensemble Health has over $20 billion in annual client net patient revenue under management.</p>\n<p>Hiring solutions provider&nbsp;<b>HireRight Holdings</b>(HRT) plans to raise $500 million at a $1.8 billion market cap. This company provides background checks, verification, identification, monitoring, and drug and health screening services to over 40,000 customers. HireRight was profitable on an EBIT basis in the 1H21, though cash flow swung negative.</p>\n<p>Online education marketplace&nbsp;<b>Udemy</b>(UDMY) plans to raise $406 million at a $4.3 billion market cap. This education platform provides over 183,000 courses in 75 languages to over 44 million customers in over 180 countries. Growing but unprofitable, Udemy has registered more than 73 million users since its inception.</p>\n<p>Chinese drug in-licensor&nbsp;<b>LianBio</b>(LIAN) plans to raise $325 million at a $1.8 billion market cap. Focused on China and other Asian markets, this biopharmaceutical company develops and commercializes drugs for a variety of indications. LianBio’s pipeline currently consists of nine product candidates across five different therapeutics areas.</p>\n<p><b>Rent the Runway</b>(RENT) plans to raise $293 million at a $1.4 billion market cap. This apparel rental company originally focused on a-la-carte rentals of dresses for events, but has gradually transitioned to mostly generating revenue from monthly subscription boxes. While the company has seen active subscribers and revenue rebound in the last two quarters, it is unprofitable and leveraged post-IPO.</p>\n<p>Aesthetic medical device maker&nbsp;<b>Candela Medical</b>(CDLA) plans to raise $250 million at a $1.7 billion market cap. Selling products directly in 18 countries and indirectly in 66 countries, this company develops medical devices for elective aesthetic procedures. Despite being hard hit by the pandemic, Candela Medical saw strong growth and turned profitable in the 1H21.</p>\n<p>Fire pit brand&nbsp;<b>Solo Brands</b>(DTC) plans to raise $200 million at a $1.5 billion market cap. Solo Brands sells fire pits, camp stoves, and other outdoor gear through its DTC platform. Fast growing and profitable, this outdoor e-commerce has an installed base of more than 2.3 million customers.</p>\n<p>Body contouring provider&nbsp;<b>AirSculpt Technologies</b>(AIRS) plans to raise $160 million at an $886 million market cap. This company provides minimally-invasive body contouring procedures through 16 centers across 13 states in the US. AirSculpt Technologies is profitable with solid growth, and has seen an increase in same-center case volume as a result of lessening effects of COVID-19.</p>\n<p>Technology firm&nbsp;<b>Arteris</b>(AIP) plans to raise $75 million at a $555 million market cap. This technology company develops and licenses interconnect intellectual property that manages the on-chip communications in System-on-Chip semiconductor devices. Arteris is unprofitable but saw growth accelerate in the 1H21.</p>\n<p><img src=\"https://static.tigerbbs.com/99c3b0173e59f4e69ff484c12bd137e7\" tg-width=\"1270\" tg-height=\"704\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/64e34b3c49a856e99ba64a2d57410844\" tg-width=\"1272\" tg-height=\"582\" referrerpolicy=\"no-referrer\"></p>\n<p>Street research is expected for six companies, and lock-up periods will be expiring for up to 12 companies.</p>\n<p><b>IPO Market Snapshot</b></p>\n<p>The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 10/22/21, the Renaissance IPO Index was up 8.2% year-to-date, while the S&amp;P 500 was up 21.1%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Uber Technologies (UBER) and Moderna (MRNA). The Renaissance International IPO Index was down 15.8% year-to-date, while the ACWX was up 9.1%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.</p>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: Semiconductors, energy storage, designer apparel, and more in a 12 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: Semiconductors, energy storage, designer apparel, and more in a 12 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-24 08:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/87676/US-IPO-Week-Ahead-Semiconductors-energy-storage-designer-apparel-and-more-i><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The IPO market continues to stay busy with 12 IPOs schedule to raise $6.8 billion in the week ahead.\nSemiconductor foundry GlobalFoundries(GFS) plans to raise $2.4 billion at a $24.6 billion market ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/87676/US-IPO-Week-Ahead-Semiconductors-energy-storage-designer-apparel-and-more-i\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","INFA":"Informatica Inc.","UDMY":"Udemy, Inc.","RENT":"Rent the Runway, Inc.","GFS":"GLOBALFOUNDRIES Inc.",".IXIC":"NASDAQ Composite",".DJI":"道琼斯","FLNC":"Fluence Energy, Inc.","HRT":"HireRight Holdings Corp.","AIP":"Arteris, Inc.","AIRS":"Airsculpt Technologies"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/87676/US-IPO-Week-Ahead-Semiconductors-energy-storage-designer-apparel-and-more-i","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1174514229","content_text":"The IPO market continues to stay busy with 12 IPOs schedule to raise $6.8 billion in the week ahead.\nSemiconductor foundry GlobalFoundries(GFS) plans to raise $2.4 billion at a $24.6 billion market cap. Backed by Abu Dhabi’s Mubadala, US-based GlobalFoundries is one of the world’s leading specialty semiconductor foundries. Unprofitable with lumpy growth, the company states that it is the only scaled pure-play foundry with a global footprint that is not based in China.\nEnterprise cloud data management platform Informatica(INFA) plans to raise $885 million at an $8.7 billion market cap. This company provides data integration services on its AI-powered platform to over 5,700 customers through both licenses and subscriptions. Although it will be highly leveraged post-IPO, Informatica is a recognized leader in the global data management market and saw strong subscription ARR growth in the 1H21.\nEnergy storage provider Fluence Energy(FLNC) plans to raise $698 million at a $3.8 billion market cap. Formed by Siemens and AES, this company sells energy storage products and services to utilities, independent power producers, project developers, and commercial and industrial customers. Fast growing but unprofitable, Fluence Energy deployed 942 MW of storage products as of 6/30/21.\nRevenue cycle management platform Ensemble Health Partners(ENSB) plans to raise $605 million at a $3.6 billion market cap. This platform provides revenue cycle management solutions to the healthcare industry. Profitable with accelerating growth in the 1H21, Ensemble Health has over $20 billion in annual client net patient revenue under management.\nHiring solutions provider HireRight Holdings(HRT) plans to raise $500 million at a $1.8 billion market cap. This company provides background checks, verification, identification, monitoring, and drug and health screening services to over 40,000 customers. HireRight was profitable on an EBIT basis in the 1H21, though cash flow swung negative.\nOnline education marketplace Udemy(UDMY) plans to raise $406 million at a $4.3 billion market cap. This education platform provides over 183,000 courses in 75 languages to over 44 million customers in over 180 countries. Growing but unprofitable, Udemy has registered more than 73 million users since its inception.\nChinese drug in-licensor LianBio(LIAN) plans to raise $325 million at a $1.8 billion market cap. Focused on China and other Asian markets, this biopharmaceutical company develops and commercializes drugs for a variety of indications. LianBio’s pipeline currently consists of nine product candidates across five different therapeutics areas.\nRent the Runway(RENT) plans to raise $293 million at a $1.4 billion market cap. This apparel rental company originally focused on a-la-carte rentals of dresses for events, but has gradually transitioned to mostly generating revenue from monthly subscription boxes. While the company has seen active subscribers and revenue rebound in the last two quarters, it is unprofitable and leveraged post-IPO.\nAesthetic medical device maker Candela Medical(CDLA) plans to raise $250 million at a $1.7 billion market cap. Selling products directly in 18 countries and indirectly in 66 countries, this company develops medical devices for elective aesthetic procedures. Despite being hard hit by the pandemic, Candela Medical saw strong growth and turned profitable in the 1H21.\nFire pit brand Solo Brands(DTC) plans to raise $200 million at a $1.5 billion market cap. Solo Brands sells fire pits, camp stoves, and other outdoor gear through its DTC platform. Fast growing and profitable, this outdoor e-commerce has an installed base of more than 2.3 million customers.\nBody contouring provider AirSculpt Technologies(AIRS) plans to raise $160 million at an $886 million market cap. This company provides minimally-invasive body contouring procedures through 16 centers across 13 states in the US. AirSculpt Technologies is profitable with solid growth, and has seen an increase in same-center case volume as a result of lessening effects of COVID-19.\nTechnology firm Arteris(AIP) plans to raise $75 million at a $555 million market cap. This technology company develops and licenses interconnect intellectual property that manages the on-chip communications in System-on-Chip semiconductor devices. Arteris is unprofitable but saw growth accelerate in the 1H21.\n\nStreet research is expected for six companies, and lock-up periods will be expiring for up to 12 companies.\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 10/22/21, the Renaissance IPO Index was up 8.2% year-to-date, while the S&P 500 was up 21.1%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Uber Technologies (UBER) and Moderna (MRNA). The Renaissance International IPO Index was down 15.8% year-to-date, while the ACWX was up 9.1%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"AIP":0.9,"AIRS":0.9,"CDLA":0.9,"DTC":0.9,"ENSB":0.9,"FLNC":0.9,"GFS":0.9,"HRT":0.9,"INFA":0.9,"LIAN":0.9,"RENT":0.9,"UDMY":0.9}},"isVote":1,"tweetType":1,"viewCount":540,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605890559,"gmtCreate":1639140185647,"gmtModify":1639140186020,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thank you","listText":"Please like, thank you","text":"Please like, thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/605890559","repostId":"1100115506","repostType":4,"repost":{"id":"1100115506","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639138188,"share":"https://www.laohu8.com/m/news/1100115506?lang=&edition=full","pubTime":"2021-12-10 20:09","market":"us","language":"en","title":"Some vaccine stocks dropped in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1100115506","media":"Tiger Newspress","summary":"Some vaccine stocks dropped in premarket trading.Moderna fell more than 6%,BioNTech and Novavax fell","content":"<p>Some vaccine stocks dropped in premarket trading.Moderna fell more than 6%,BioNTech and Novavax fell about 2%.</p>\n<p><img src=\"https://static.tigerbbs.com/8a520d484bb38c42dea515aeca96c8b3\" tg-width=\"843\" tg-height=\"623\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/3f4e9ce656bcb771198057d217489677\" tg-width=\"843\" tg-height=\"618\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/fd626ba47bec50af63916a31695eca4c\" tg-width=\"843\" tg-height=\"621\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Some vaccine stocks dropped in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSome vaccine stocks dropped in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-10 20:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Some vaccine stocks dropped in premarket trading.Moderna fell more than 6%,BioNTech and Novavax fell about 2%.</p>\n<p><img src=\"https://static.tigerbbs.com/8a520d484bb38c42dea515aeca96c8b3\" tg-width=\"843\" tg-height=\"623\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/3f4e9ce656bcb771198057d217489677\" tg-width=\"843\" tg-height=\"618\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/fd626ba47bec50af63916a31695eca4c\" tg-width=\"843\" tg-height=\"621\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","BNTX":"BioNTech SE","NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100115506","content_text":"Some vaccine stocks dropped in premarket trading.Moderna fell more than 6%,BioNTech and Novavax fell about 2%.","news_type":1,"symbols_score_info":{"BNTX":0.9,"MRNA":0.9,"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":2396,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602368027,"gmtCreate":1638973718285,"gmtModify":1638973718679,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks&nbsp;","listText":"Please like, thanks&nbsp;","text":"Please like, thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/602368027","repostId":"1180032077","repostType":4,"isVote":1,"tweetType":1,"viewCount":3050,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879611243,"gmtCreate":1636715530802,"gmtModify":1636715530939,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks!","listText":"Please like, thanks!","text":"Please like, thanks!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/879611243","repostId":"1144158970","repostType":4,"repost":{"id":"1144158970","kind":"news","pubTimestamp":1636702548,"share":"https://www.laohu8.com/m/news/1144158970?lang=&edition=full","pubTime":"2021-11-12 15:35","market":"us","language":"en","title":"Why the hottest inflation in 3 decades isn’t rattling stock-market bulls","url":"https://stock-news.laohu8.com/highlight/detail?id=1144158970","media":"Marketwatch","summary":"Stock market investors still aren’t sweating rising inflation pressures that saw U.S. consumer price","content":"<p>Stock market investors still aren’t sweating rising inflation pressures that saw U.S. consumer prices rise 6.2% year-over-year in October, a nearly 31-year high. And that might not change until the Federal Reserve gets more aggressive, analysts said.</p>\n<p>“U.S. equities have shrugged off this year’s surge in inflation, probably because it has not coincided with either a rise in the real yields of Treasurys or weakness in corporate earnings,” said Oliver Allen, markets economist at Capital Economics, in a Thursday note. The real yield is the yield an investor receives after accounting for inflation.</p>\n<p>Markets were briefly roiled following the October Consumer Price Index reading on Wednesday. Nominal Treasury yields rose sharply, weighing on stocks, particularly technology and other growth-oriented sectors seen as most sensitive to rising interest rates.</p>\n<p>Equities were stable Thursday, while the Treasury market was closed for the U.S. Veterans Day holiday. The tech-heavy Nasdaq Composite , which fell more than 1% on Wednesday, was up 0.7% Thursday, while the S&amp;P 500&nbsp;edged up 0.1% and the Dow Jones Industrial Average&nbsp;lost 0.4%.</p>\n<p>All three major indexes remain not far off all-time highs, coming off a robust third-quarter earnings season that saw companies maintain profit margins and maintain relatively upbeat guidance.</p>\n<p>Inflation, of course, isn’t necessarily a negative for equities. Stocks are viewed as real assets, which means they tend to appreciate in an inflationary environment, making them a useful hedge against inflation pressures. Also, analysts at Quant Insights, say that stocks have grown less sensitive overall to inflation pressures since 2015.</p>\n<p>However, inflation well above the low single digits, as was the case in much of the 1970s and early 1980, has tended to coincide with lower stock-market valuations due to the negative effects of rising prices on economic growth or the Fed tightening monetary policy to bring inflation back down, Allen noted.</p>\n<p>But despite inflation running in what would appear to be the danger zone, Allen noted that real, or inflation-adjusted interest rates, haven’t risen significantly at either the short or long end of the yield curve.</p>\n<p>While the October CPI release prompted a small rise in the yield on 10-year U.S. Treasury inflation protected securities on Wednesday, the general pattern of the past six months has been characterized by falling real yields that have appeared to push U.S. equities higher, Allen said (see chart below).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/077484a8788885d4c202fb3d6a80bd17\" tg-width=\"700\" tg-height=\"498\" width=\"100%\" height=\"auto\"><span>Capital Economics</span></p>\n<p>Meanwhile, the sharp, one-day rise in the 10-year Treasury yield and moves in fed funds futures on Wednesday reflected expectations the Fed will accelerate the wind-down of its asset-buying program and begin lifting its policy interest rates in 2022 sooner and more aggressively than expected. But it didn’t indicate investors fear a long-lasting run of high inflation, said Nicholas Colas, co-founder of DataTrek Research, in a Thursday note.</p>\n<p>The market action on Wednesday “was all about investors adjusting their views on Fed policy. If [investors] really thought plus-6% inflation was the ‘new normal,’ asset prices would be much, much lower,” Colas wrote.</p>\n<p>And while the breakeven rate on five-year Treasury inflation protected securities hit a new high, they’re still signaling expectations for inflation of just 3% over the next half-decade, he said.</p>\n<p>Some investors do fear the Fed has already lost control of inflation and inflation expectations. As result, policy makers may need to tighten monetary policy much more aggressively than anticipated, potentially leading to a sharp economic downturn.</p>\n<p>But some stock-market watchers expect stocks to remain supported until policy makers show signs they’re prepared to take more aggressive action.</p>\n<p>The rise in bond yields on Wednesday marked a bounce from a sharp two-week decline that wasn’t based on fundamentals and was, therefore, unlikely to last, said Tom Essaye, founder of Sevens Report Research, in a Thursday note.</p>\n<p>“During that period, tech rallied and led markets higher, and we’re seeing both trades now unwind. And given tech’s large weighting, that will be a headwind on the S&amp;P 500,” he said.</p>\n<p>“But unless the Fed starts strongly hinting at an accelerated taper or a much- sooner-than-expected rate hike, we do not see yesterday’s hot CPI or rise in yields as a reason to get more defensive,” he said, arguing it was instead reminder of the dominant trends in the market: above-normal inflation and rising yields.</p>\n<p>A policy shift by the Fed could come before year-end, potentially spelling trouble for stocks, warned Jeremy Siegel, finance professor at the University of Pennsylvania’s Wharton School. in a CNBC interview on Wednesday.</p>\n<p>“Listen, stocks love inflation until the Fed gets serious about it and they have not been serious about it,” he said, warning that more inflation data in line with the October report before the central bank’s mid-December policy meeting would put “enormous” pressure on Chairman Jerome Powell “to come down much stronger than he has so far.”</p>\n<p>Allen said Capital Economics expects the Fed to follow through with a “modest tightening in the real stance of monetary policy,” accompanied by a grind higher for U.S. TIPS yields.</p>\n<p>“The tailwind of falling real yields turning into a modest headwind is one reason why we think U.S. equities will struggle to make gains over the next couple of years,” Allen wrote. “Another reason is that we think the recovery in the US economy will fall short of investors’ expectations.”</p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why the hottest inflation in 3 decades isn’t rattling stock-market bulls</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy the hottest inflation in 3 decades isn’t rattling stock-market bulls\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-12 15:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/why-the-hottest-inflation-in-3-decades-isnt-rattling-stock-market-bulls-11636661515?siteid=yhoof2><strong>Marketwatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stock market investors still aren’t sweating rising inflation pressures that saw U.S. consumer prices rise 6.2% year-over-year in October, a nearly 31-year high. And that might not change until the ...</p>\n\n<a href=\"https://www.marketwatch.com/story/why-the-hottest-inflation-in-3-decades-isnt-rattling-stock-market-bulls-11636661515?siteid=yhoof2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://www.marketwatch.com/story/why-the-hottest-inflation-in-3-decades-isnt-rattling-stock-market-bulls-11636661515?siteid=yhoof2","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1144158970","content_text":"Stock market investors still aren’t sweating rising inflation pressures that saw U.S. consumer prices rise 6.2% year-over-year in October, a nearly 31-year high. And that might not change until the Federal Reserve gets more aggressive, analysts said.\n“U.S. equities have shrugged off this year’s surge in inflation, probably because it has not coincided with either a rise in the real yields of Treasurys or weakness in corporate earnings,” said Oliver Allen, markets economist at Capital Economics, in a Thursday note. The real yield is the yield an investor receives after accounting for inflation.\nMarkets were briefly roiled following the October Consumer Price Index reading on Wednesday. Nominal Treasury yields rose sharply, weighing on stocks, particularly technology and other growth-oriented sectors seen as most sensitive to rising interest rates.\nEquities were stable Thursday, while the Treasury market was closed for the U.S. Veterans Day holiday. The tech-heavy Nasdaq Composite , which fell more than 1% on Wednesday, was up 0.7% Thursday, while the S&P 500 edged up 0.1% and the Dow Jones Industrial Average lost 0.4%.\nAll three major indexes remain not far off all-time highs, coming off a robust third-quarter earnings season that saw companies maintain profit margins and maintain relatively upbeat guidance.\nInflation, of course, isn’t necessarily a negative for equities. Stocks are viewed as real assets, which means they tend to appreciate in an inflationary environment, making them a useful hedge against inflation pressures. Also, analysts at Quant Insights, say that stocks have grown less sensitive overall to inflation pressures since 2015.\nHowever, inflation well above the low single digits, as was the case in much of the 1970s and early 1980, has tended to coincide with lower stock-market valuations due to the negative effects of rising prices on economic growth or the Fed tightening monetary policy to bring inflation back down, Allen noted.\nBut despite inflation running in what would appear to be the danger zone, Allen noted that real, or inflation-adjusted interest rates, haven’t risen significantly at either the short or long end of the yield curve.\nWhile the October CPI release prompted a small rise in the yield on 10-year U.S. Treasury inflation protected securities on Wednesday, the general pattern of the past six months has been characterized by falling real yields that have appeared to push U.S. equities higher, Allen said (see chart below).\nCapital Economics\nMeanwhile, the sharp, one-day rise in the 10-year Treasury yield and moves in fed funds futures on Wednesday reflected expectations the Fed will accelerate the wind-down of its asset-buying program and begin lifting its policy interest rates in 2022 sooner and more aggressively than expected. But it didn’t indicate investors fear a long-lasting run of high inflation, said Nicholas Colas, co-founder of DataTrek Research, in a Thursday note.\nThe market action on Wednesday “was all about investors adjusting their views on Fed policy. If [investors] really thought plus-6% inflation was the ‘new normal,’ asset prices would be much, much lower,” Colas wrote.\nAnd while the breakeven rate on five-year Treasury inflation protected securities hit a new high, they’re still signaling expectations for inflation of just 3% over the next half-decade, he said.\nSome investors do fear the Fed has already lost control of inflation and inflation expectations. As result, policy makers may need to tighten monetary policy much more aggressively than anticipated, potentially leading to a sharp economic downturn.\nBut some stock-market watchers expect stocks to remain supported until policy makers show signs they’re prepared to take more aggressive action.\nThe rise in bond yields on Wednesday marked a bounce from a sharp two-week decline that wasn’t based on fundamentals and was, therefore, unlikely to last, said Tom Essaye, founder of Sevens Report Research, in a Thursday note.\n“During that period, tech rallied and led markets higher, and we’re seeing both trades now unwind. And given tech’s large weighting, that will be a headwind on the S&P 500,” he said.\n“But unless the Fed starts strongly hinting at an accelerated taper or a much- sooner-than-expected rate hike, we do not see yesterday’s hot CPI or rise in yields as a reason to get more defensive,” he said, arguing it was instead reminder of the dominant trends in the market: above-normal inflation and rising yields.\nA policy shift by the Fed could come before year-end, potentially spelling trouble for stocks, warned Jeremy Siegel, finance professor at the University of Pennsylvania’s Wharton School. in a CNBC interview on Wednesday.\n“Listen, stocks love inflation until the Fed gets serious about it and they have not been serious about it,” he said, warning that more inflation data in line with the October report before the central bank’s mid-December policy meeting would put “enormous” pressure on Chairman Jerome Powell “to come down much stronger than he has so far.”\nAllen said Capital Economics expects the Fed to follow through with a “modest tightening in the real stance of monetary policy,” accompanied by a grind higher for U.S. TIPS yields.\n“The tailwind of falling real yields turning into a modest headwind is one reason why we think U.S. equities will struggle to make gains over the next couple of years,” Allen wrote. “Another reason is that we think the recovery in the US economy will fall short of investors’ expectations.”","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":745,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600839486,"gmtCreate":1638114455737,"gmtModify":1638114455964,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks&nbsp;","listText":"Please like, thanks&nbsp;","text":"Please like, thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/600839486","repostId":"2186432895","repostType":4,"isVote":1,"tweetType":1,"viewCount":1767,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":857009341,"gmtCreate":1635489924549,"gmtModify":1635489924947,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thank you","listText":"Please like, thank you","text":"Please like, thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/857009341","repostId":"1122237204","repostType":4,"isVote":1,"tweetType":1,"viewCount":549,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":814194804,"gmtCreate":1630790708208,"gmtModify":1631888728641,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Like my comment, thanks!","listText":"Like my comment, thanks!","text":"Like my comment, thanks!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/814194804","repostId":"1169514310","repostType":4,"repost":{"id":"1169514310","kind":"news","pubTimestamp":1630656896,"share":"https://www.laohu8.com/m/news/1169514310?lang=&edition=full","pubTime":"2021-09-03 16:14","market":"us","language":"en","title":"2 Good Reasons the Stock Market Isn’t Ready to Blow Up Yet","url":"https://stock-news.laohu8.com/highlight/detail?id=1169514310","media":"Barron's","summary":"tocks have had an impressive year so far, but there are still four months before 2021 wraps up. So w","content":"<p>tocks have had an impressive year so far, but there are still four months before 2021 wraps up. So what’s ahead? A correction? More gains? Right now, it’s easier to make the case for the rally to just keep on going.</p>\n<p>First, though, it’s understandable why investors might be nervous.</p>\n<p>TheS&amp;P 500has gained about 21% year to date, far above the historical average annual return of about 10%. And in the first eight months, the index hasn’t had a pullback of more than 5%— a correction is defined as a 10% drawdown.</p>\n<p>Still, a good run needs something to stop it—likehigher corporate taxes,which the Biden administration supports. They could shave 5% or more off projected earnings estimates for S&amp;P 500 companies. Or persistent inflation, which could cause the Federal Reserve to rapidly reduce economic support. And there are a host of other catalysts, enough to push some analyststo forecast a retreat.</p>\n<p>But who knows how long Washington might take to put a new tax structure in place, or if lawmakers even will. Or what the deal is with inflation. There has been tapering talk for a few months now, and the Fed holds firm to its wait-and-see approach.</p>\n<p>So the nature of the market’s climb in the past couple of weeks seems to be the surest, strongest sign of what’s ahead. The S&amp;P 500 is up 3% since Aug. 18, the bottom of a brief and shallow drop.</p>\n<p>“[Market] internals improved last week,” writes&nbsp;Michael Gibbs, director of equity portfolio and technical strategy at Raymond James.</p>\n<p>First off, transaction volumes are improving.</p>\n<p>In late August, the daily number of shares traded on the&nbsp;SPDR S&amp;P 500 Exchange-Traded Fund Trust(SPY) has been about 54 million, according to FactSet. That’s above just under 50 million seen in the middle of the month.</p>\n<p>The upshot: When more market participants are transacting and they are bidding prices higher, it’s a vote of confidence in the market.</p>\n<p>Secondly, the rally has been broad-based—many stocks have participated. For example, almost 80% of stocks listed on the New York Stock Exchange have been gaining, according to Raymond James.</p>\n<p>The last time that metric hit such a high was November 2020. More stocks participating in the rally means the major indexes are less dependent on one group of stocks to move higher. Plus, witheconomically sensitive stocks on a run as well,it means investors are confident in sustained economic growth ahead.</p>\n<p>So more gains or a correction? We’ve made our case, but time will tell.</p>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Good Reasons the Stock Market Isn’t Ready to Blow Up Yet</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Good Reasons the Stock Market Isn’t Ready to Blow Up Yet\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-03 16:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/stock-market-outlook-crash-or-rally-51630526109?siteid=yhoof2><strong>Barron's</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>tocks have had an impressive year so far, but there are still four months before 2021 wraps up. So what’s ahead? A correction? More gains? Right now, it’s easier to make the case for the rally to just...</p>\n\n<a href=\"https://www.barrons.com/articles/stock-market-outlook-crash-or-rally-51630526109?siteid=yhoof2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index","SPY":"标普500ETF",".DJI":"道琼斯"},"source_url":"https://www.barrons.com/articles/stock-market-outlook-crash-or-rally-51630526109?siteid=yhoof2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1169514310","content_text":"tocks have had an impressive year so far, but there are still four months before 2021 wraps up. So what’s ahead? A correction? More gains? Right now, it’s easier to make the case for the rally to just keep on going.\nFirst, though, it’s understandable why investors might be nervous.\nTheS&P 500has gained about 21% year to date, far above the historical average annual return of about 10%. And in the first eight months, the index hasn’t had a pullback of more than 5%— a correction is defined as a 10% drawdown.\nStill, a good run needs something to stop it—likehigher corporate taxes,which the Biden administration supports. They could shave 5% or more off projected earnings estimates for S&P 500 companies. Or persistent inflation, which could cause the Federal Reserve to rapidly reduce economic support. And there are a host of other catalysts, enough to push some analyststo forecast a retreat.\nBut who knows how long Washington might take to put a new tax structure in place, or if lawmakers even will. Or what the deal is with inflation. There has been tapering talk for a few months now, and the Fed holds firm to its wait-and-see approach.\nSo the nature of the market’s climb in the past couple of weeks seems to be the surest, strongest sign of what’s ahead. The S&P 500 is up 3% since Aug. 18, the bottom of a brief and shallow drop.\n“[Market] internals improved last week,” writes Michael Gibbs, director of equity portfolio and technical strategy at Raymond James.\nFirst off, transaction volumes are improving.\nIn late August, the daily number of shares traded on the SPDR S&P 500 Exchange-Traded Fund Trust(SPY) has been about 54 million, according to FactSet. That’s above just under 50 million seen in the middle of the month.\nThe upshot: When more market participants are transacting and they are bidding prices higher, it’s a vote of confidence in the market.\nSecondly, the rally has been broad-based—many stocks have participated. For example, almost 80% of stocks listed on the New York Stock Exchange have been gaining, according to Raymond James.\nThe last time that metric hit such a high was November 2020. More stocks participating in the rally means the major indexes are less dependent on one group of stocks to move higher. Plus, witheconomically sensitive stocks on a run as well,it means investors are confident in sustained economic growth ahead.\nSo more gains or a correction? We’ve made our case, but time will tell.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"SPY":0.9}},"isVote":1,"tweetType":1,"viewCount":501,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":608740082,"gmtCreate":1638794956515,"gmtModify":1638795937524,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks","listText":"Please like, thanks","text":"Please like, thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/608740082","repostId":"1191828969","repostType":4,"repost":{"id":"1191828969","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638792831,"share":"https://www.laohu8.com/m/news/1191828969?lang=&edition=full","pubTime":"2021-12-06 20:13","market":"us","language":"en","title":"Grab shares slid more than 4% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1191828969","media":"Tiger Newspress","summary":"Grab shares slid more than 4% in premarket trading.The&nbsp;Singapore ride-hailing firm&nbsp;went on sale last week.","content":"<p>Grab shares slid more than 4% in premarket trading.The&nbsp;Singapore ride-hailing firm&nbsp;went on sale last week.</p>\n<p><img src=\"https://static.tigerbbs.com/8de30b544b65a645e7a91a37bfb8d8f8\" tg-width=\"851\" tg-height=\"618\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Grab shares slid more than 4% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGrab shares slid more than 4% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-06 20:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Grab shares slid more than 4% in premarket trading.The&nbsp;Singapore ride-hailing firm&nbsp;went on sale last week.</p>\n<p><img src=\"https://static.tigerbbs.com/8de30b544b65a645e7a91a37bfb8d8f8\" tg-width=\"851\" tg-height=\"618\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRAB":"Grab Holdings"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191828969","content_text":"Grab shares slid more than 4% in premarket trading.The Singapore ride-hailing firm went on sale last week.","news_type":1,"symbols_score_info":{"GRAB":0.9}},"isVote":1,"tweetType":1,"viewCount":2262,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609694359,"gmtCreate":1638275659492,"gmtModify":1638275659636,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks","listText":"Please like, thanks","text":"Please like, thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/609694359","repostId":"1192203085","repostType":4,"repost":{"id":"1192203085","kind":"news","pubTimestamp":1638273550,"share":"https://www.laohu8.com/m/news/1192203085?lang=&edition=full","pubTime":"2021-11-30 19:59","market":"us","language":"en","title":"Covid-19 Antibody Drugs Are Challenged by Omicron, Preliminary Testing Indicates","url":"https://stock-news.laohu8.com/highlight/detail?id=1192203085","media":"The Wall Street Journal","summary":"Regeneron said its antibody drug cocktail was found to lose effectiveness against the new variant\nA ","content":"<p>Regeneron said its antibody drug cocktail was found to lose effectiveness against the new variant</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ed6086131617e6933fe07f3e46cd5c26\" tg-width=\"1290\" tg-height=\"859\" referrerpolicy=\"no-referrer\"><span>A monoclonal antibody treatment site in Pembroke Pines, Fla., earlier this year.</span></p>\n<p>Preliminary tests indicate the Covid-19 antibody drug cocktail from Regeneron Pharmaceuticals Inc. loses effectiveness against Omicron, the company said Tuesday, a sign that some products in an important class of therapies might need modifying if the new strain becomes widespread.</p>\n<p>Separate testing of another authorized Covid-19 antibody drug cocktail, from&nbsp;Eli Lilly&amp; Co., indicates it also isn’t as effective against Omicron, outside scientists said. Lilly said it is testing the new variant against its antibody treatment and wouldn’t speculate on what the results will be.</p>\n<p>The findings are the early results of researchers’ race to assess the impact of the&nbsp;new Omicron variant&nbsp;on Covid-19 treatments that patients, doctors and hospitals have been relying on, as well as pills in development that have promised to keep people out of the hospital.</p>\n<p>Researchers say some antibody therapies are likely to be especially vulnerable to Omicron because it contains mutations to the spike protein that the Regeneron and Lilly drugs target, while other drugs should hold up well because they attack elements of the virus unchanged in the variant.</p>\n<p>Monoclonal antibodies are lab-made molecules derived from survivors of Covid-19 or mice engineered to have human immune systems. When given soon after infection, the drugs attach to the surface of the coronavirus and prevent it from replicating itself in new cells.</p>\n<p>They are the only drugs authorized to treat patients, before they require hospitalization, who are at high risk of developing severe cases.</p>\n<p>The drugs differ from vaccines, which train the immune system how to defend against the virus, including with the production of antibodies. Last year, former&nbsp;President Donald Trump credited Regeneron’s drug&nbsp;with his speedy recovery from Covid-19.</p>\n<p>Regeneron said it would be able to quantify the impact of the variant in coming weeks, after further testing is done.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6e7fac5c4630025e6c5ad28d2c3efbfa\" tg-width=\"1050\" tg-height=\"700\" referrerpolicy=\"no-referrer\"><span>Antiviral pills such as Pfizer’s Paxlovid appear to be unaffected by the variant.</span></p>\n<p>If final testing shows that its antibody drugs are less effective against Omicron, Regeneron has developed alternative antibodies that it can push into clinical testing and that it thinks will retain effectiveness against the variant, said George Yancopoulos, the company’s president and chief scientific officer.</p>\n<p>One of Regeneron’s alternative antibodies is already in clinical testing, which the company began in anticipation of new variants emerging over time.</p>\n<p>The Omicron variant was identified last week by scientists in South Africa, prompting drug researchers to scramble to see if the relatively small medicine chest of Covid-19 treatments would still work against the new strain if it ends up spreading widely.</p>\n<p>“What we have to admit is, in the course of the past six days, our urgency has increased,” Dr. Yancopoulos said in an interview. “What started out as a backup plan has now been made a lot more urgent.”</p>\n<p>Scientists at the Fred Hutchinson Cancer Research Center in Seattle found that individual mutations from Omicron reduced or eliminated the ability of Regeneron’s and Lilly’s drugs to attach to the virus, said Allie Greaney, a Ph.D. candidate at the center and the University of Washington in Seattle.</p>\n<p>More comprehensive tests of the drugs against the entire variant are needed to fully understand the impact, she said. “I’m not certain what the exact magnitude of effect would be, but probably less effective,” said Ms. Greaney.</p>\n<p>Lilly is in the process of testing the new variant against its drug, a combination of&nbsp;two antibodies called bamlanivimab and etesevimab,said Nicole Kallewaard, a Lilly virologist and research adviser.</p>\n<p>She declined to comment on the results showing reduced effectiveness against individual Omicron mutations, because the results may differ when all of the mutations are combined.</p>\n<p>“I think that we need to wait for confirmation of the whole virus,” said Dr. Kallewaard. “Hopefully, the data will come in the next few weeks.”</p>\n<p>A rise in the prevalence of Omicron could present an opportunity for competitors who say their drugs don’t appear in preliminary testing to be affected by the variant, including&nbsp;Vir Biotechnology&nbsp;Inc.&nbsp;and GlaxoSmithKline PLC, whose drug&nbsp;sotrovimab was authorized for emergency use&nbsp;earlier this year.</p>\n<p>Fred Hutchinson researchers also said their initial testing indicated the Vir-GSK antibody drug retained its effectiveness.</p>\n<p>Adagio Therapeutics&nbsp;Inc.,a biotech with a Covid-19 antibody drug in clinical trials, said its antibody also appears to be unaffected by the new variant.</p>\n<p>Vir, Glaxo and Adagio said they are conducting further tests to confirm that their drugs aren’t affected by Omicron.</p>\n<p>Omicron poses a threat to lab-made antibody drugs as well as antibodies generated by vaccines, because the new variant has mutations on the spike protein part of the virus where antibodies are known to frequently attach themselves, scientists say.</p>\n<p>Vir and Adagio officials said the companies designed their antibodies with the aim of targeting spots on the virus that are common across different coronaviruses that remained stable even after numerous mutations over many years.</p>\n<p>“They bind to a region of the virus that through decades of evolution has not changed a lot,” Adagio Chief Executive Tillman Gerngross said in an interview. “Those conserved areas make the virus much more vulnerable” to antibodies.</p>\n<p>It will take at least two weeks to create a version of the full Omicron virus variant and test antibody drugs against it, company officials said. Still, scientists say they are concerned by what they know already about the variant’s ability to evade antibodies produced by vaccines, prior infection or from drug treatment.</p>\n<p>“Omicron hasn’t become the next Delta,” Vir Chief Scientific Officer Skip Virgin said in an interview. But “we think the extent of the mutations, the number of them, means that the world needs to take Omicron very seriously.”</p>\n<p>Antiviral drugs, including pills from&nbsp;Merck&amp; Co. and partner Ridgeback Biotherapeutics LP and from&nbsp;Pfizer&nbsp;Inc.&nbsp;that are being&nbsp;evaluated for authorization,appear to be unaffected by the variant because they target a different site on the virus, said Michel Nussenzweig, an immunologist at Rockefeller University.</p>\n<p>Doctors and patients have been looking forward to authorization of the pills, which in clinical trials have&nbsp;reduced the risk of hospitalization&nbsp;if taken early enough.</p>\n<p>“The targets of the pills appear to be under less pressure and may be OK, but this too needs to be tested,” said Dr. Nussenzweig.</p>\n<p>Pfizer and Merck said they expect their drugs to be effective against Omicron.</p>\n<p>Gilead SciencesInc.&nbsp;also said it expects&nbsp;Veklury, its antiviral drug&nbsp;used to treat hospitalized patients, to retain effectiveness against Omicron as it has against other variants of concern.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Covid-19 Antibody Drugs Are Challenged by Omicron, Preliminary Testing Indicates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCovid-19 Antibody Drugs Are Challenged by Omicron, Preliminary Testing Indicates\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 19:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/covid-19-antibody-drugs-are-challenged-by-omicron-preliminary-testing-indicates-11638270003?mod=Searchresults_pos1&page=1><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Regeneron said its antibody drug cocktail was found to lose effectiveness against the new variant\nA monoclonal antibody treatment site in Pembroke Pines, Fla., earlier this year.\nPreliminary tests ...</p>\n\n<a href=\"https://www.wsj.com/articles/covid-19-antibody-drugs-are-challenged-by-omicron-preliminary-testing-indicates-11638270003?mod=Searchresults_pos1&page=1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来","REGN":"再生元制药公司"},"source_url":"https://www.wsj.com/articles/covid-19-antibody-drugs-are-challenged-by-omicron-preliminary-testing-indicates-11638270003?mod=Searchresults_pos1&page=1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1192203085","content_text":"Regeneron said its antibody drug cocktail was found to lose effectiveness against the new variant\nA monoclonal antibody treatment site in Pembroke Pines, Fla., earlier this year.\nPreliminary tests indicate the Covid-19 antibody drug cocktail from Regeneron Pharmaceuticals Inc. loses effectiveness against Omicron, the company said Tuesday, a sign that some products in an important class of therapies might need modifying if the new strain becomes widespread.\nSeparate testing of another authorized Covid-19 antibody drug cocktail, from Eli Lilly& Co., indicates it also isn’t as effective against Omicron, outside scientists said. Lilly said it is testing the new variant against its antibody treatment and wouldn’t speculate on what the results will be.\nThe findings are the early results of researchers’ race to assess the impact of the new Omicron variant on Covid-19 treatments that patients, doctors and hospitals have been relying on, as well as pills in development that have promised to keep people out of the hospital.\nResearchers say some antibody therapies are likely to be especially vulnerable to Omicron because it contains mutations to the spike protein that the Regeneron and Lilly drugs target, while other drugs should hold up well because they attack elements of the virus unchanged in the variant.\nMonoclonal antibodies are lab-made molecules derived from survivors of Covid-19 or mice engineered to have human immune systems. When given soon after infection, the drugs attach to the surface of the coronavirus and prevent it from replicating itself in new cells.\nThey are the only drugs authorized to treat patients, before they require hospitalization, who are at high risk of developing severe cases.\nThe drugs differ from vaccines, which train the immune system how to defend against the virus, including with the production of antibodies. Last year, former President Donald Trump credited Regeneron’s drug with his speedy recovery from Covid-19.\nRegeneron said it would be able to quantify the impact of the variant in coming weeks, after further testing is done.\nAntiviral pills such as Pfizer’s Paxlovid appear to be unaffected by the variant.\nIf final testing shows that its antibody drugs are less effective against Omicron, Regeneron has developed alternative antibodies that it can push into clinical testing and that it thinks will retain effectiveness against the variant, said George Yancopoulos, the company’s president and chief scientific officer.\nOne of Regeneron’s alternative antibodies is already in clinical testing, which the company began in anticipation of new variants emerging over time.\nThe Omicron variant was identified last week by scientists in South Africa, prompting drug researchers to scramble to see if the relatively small medicine chest of Covid-19 treatments would still work against the new strain if it ends up spreading widely.\n“What we have to admit is, in the course of the past six days, our urgency has increased,” Dr. Yancopoulos said in an interview. “What started out as a backup plan has now been made a lot more urgent.”\nScientists at the Fred Hutchinson Cancer Research Center in Seattle found that individual mutations from Omicron reduced or eliminated the ability of Regeneron’s and Lilly’s drugs to attach to the virus, said Allie Greaney, a Ph.D. candidate at the center and the University of Washington in Seattle.\nMore comprehensive tests of the drugs against the entire variant are needed to fully understand the impact, she said. “I’m not certain what the exact magnitude of effect would be, but probably less effective,” said Ms. Greaney.\nLilly is in the process of testing the new variant against its drug, a combination of two antibodies called bamlanivimab and etesevimab,said Nicole Kallewaard, a Lilly virologist and research adviser.\nShe declined to comment on the results showing reduced effectiveness against individual Omicron mutations, because the results may differ when all of the mutations are combined.\n“I think that we need to wait for confirmation of the whole virus,” said Dr. Kallewaard. “Hopefully, the data will come in the next few weeks.”\nA rise in the prevalence of Omicron could present an opportunity for competitors who say their drugs don’t appear in preliminary testing to be affected by the variant, including Vir Biotechnology Inc. and GlaxoSmithKline PLC, whose drug sotrovimab was authorized for emergency use earlier this year.\nFred Hutchinson researchers also said their initial testing indicated the Vir-GSK antibody drug retained its effectiveness.\nAdagio Therapeutics Inc.,a biotech with a Covid-19 antibody drug in clinical trials, said its antibody also appears to be unaffected by the new variant.\nVir, Glaxo and Adagio said they are conducting further tests to confirm that their drugs aren’t affected by Omicron.\nOmicron poses a threat to lab-made antibody drugs as well as antibodies generated by vaccines, because the new variant has mutations on the spike protein part of the virus where antibodies are known to frequently attach themselves, scientists say.\nVir and Adagio officials said the companies designed their antibodies with the aim of targeting spots on the virus that are common across different coronaviruses that remained stable even after numerous mutations over many years.\n“They bind to a region of the virus that through decades of evolution has not changed a lot,” Adagio Chief Executive Tillman Gerngross said in an interview. “Those conserved areas make the virus much more vulnerable” to antibodies.\nIt will take at least two weeks to create a version of the full Omicron virus variant and test antibody drugs against it, company officials said. Still, scientists say they are concerned by what they know already about the variant’s ability to evade antibodies produced by vaccines, prior infection or from drug treatment.\n“Omicron hasn’t become the next Delta,” Vir Chief Scientific Officer Skip Virgin said in an interview. But “we think the extent of the mutations, the number of them, means that the world needs to take Omicron very seriously.”\nAntiviral drugs, including pills from Merck& Co. and partner Ridgeback Biotherapeutics LP and from Pfizer Inc. that are being evaluated for authorization,appear to be unaffected by the variant because they target a different site on the virus, said Michel Nussenzweig, an immunologist at Rockefeller University.\nDoctors and patients have been looking forward to authorization of the pills, which in clinical trials have reduced the risk of hospitalization if taken early enough.\n“The targets of the pills appear to be under less pressure and may be OK, but this too needs to be tested,” said Dr. Nussenzweig.\nPfizer and Merck said they expect their drugs to be effective against Omicron.\nGilead SciencesInc. also said it expects Veklury, its antiviral drug used to treat hospitalized patients, to retain effectiveness against Omicron as it has against other variants of concern.","news_type":1,"symbols_score_info":{"LLY":0.9,"REGN":0.9}},"isVote":1,"tweetType":1,"viewCount":2409,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":853278358,"gmtCreate":1634820641511,"gmtModify":1634820641924,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks!","listText":"Please like, thanks!","text":"Please like, thanks!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/853278358","repostId":"2177468666","repostType":4,"repost":{"id":"2177468666","kind":"highlight","pubTimestamp":1634819400,"share":"https://www.laohu8.com/m/news/2177468666?lang=&edition=full","pubTime":"2021-10-21 20:30","market":"us","language":"en","title":"Weekly jobless claims fall to fresh pandemic-era low of 290,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2177468666","media":"Yahoo","summary":"New weekly jobless claims held below 300,000 for a back-to-back week as labor market conditions trud","content":"<p>New weekly jobless claims held below 300,000 for a back-to-back week as labor market conditions trudged back toward pre-pandemic levels.</p>\n<p>TheLabor Department released its jobless claimsreport Thursday morning. Here were the main metrics from the print, compared to consensus estimates compiled by Bloomberg:</p>\n<ul>\n <li><b>Initial unemployment claims, week ended October 16:</b>&nbsp;290,000 vs.297,000 expected and a revised296,000 during prior week</li>\n <li><b>Continuing claims, week ended October 9:</b>&nbsp;2.481 millionvs.2.548 million expected and a revised 2.603 million during prior week</li>\n</ul>\n<p>Last week's initial unemployment claims fell by a greater-than-expected margin, bringing the number of new filings back to the lowest level since March 2020. The four-week moving average for new jobless claims also dropped by 15,250 to reach 319,750 as of last week, also marking the least since March of last year.</p>\n<p>The latest claims data reflects a labor market that has made considerable progress in reducing separations since its pandemic-era peak. However, it also still has a ways to go before returning entirely to pre-virus trends. In October 2020, new filings were coming in at a weekly rate of over 700,000, but in the same month in 2019, initial claims averaged just over 210,000.</p>\n<p><img src=\"https://static.tigerbbs.com/037a3eb5ac51386ced727a2f28beb4e3\" tg-width=\"640\" tg-height=\"563\" width=\"100%\" height=\"auto\"></p>\n<p>The steady move lower in first-time filers so far this year has coincided with a jump in demand for labor and a reluctance by employers to release those already on their payrolls amid worker scarcities.</p>\n<p>But many workers have also been departing their roles of their own volition. A record 4.3 million people quit their jobs in the U.S. in. August, based on the Labor Department's most recent data. And job openings overall were at a record high of more than 10.4 million as of the end of the summer.</p>\n<p>\"While mass layoffs have been avoided of late, helping jobless claims to decline, many who are employed feel some combination of empowerment, restlessness and/or exhaustion. This is borne out in the record number of workers quitting their jobs and strikes among union members popping up around the nation,\" Mark Hamrick, Bankrate senior economic analyst, wrote in an email on Tuesday.</p>\n<p>\"Making matters worse, inflation is eroding wage gains for some, fueling desire to find new employment with better pay, working conditions and flexibility,\" he added.</p>\n<p>Continuing jobless claims, capturing the number of individuals still claiming benefits via regular state programs, also reached a fresh pandemic-era low of 2.481 million as of early October. The insured unemployment rate, or the ratio of people on unemployment benefits divided by the overall force, dipped by 0.1 percentage points to reach 1.8% for the week ended Oct. 9.</p>\n<p></p>","source":"lsy1584348713084","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Weekly jobless claims fall to fresh pandemic-era low of 290,000</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWeekly jobless claims fall to fresh pandemic-era low of 290,000\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-21 20:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/weekly-jobless-claims-week-ended-october-16-2021-193313259.html><strong>Yahoo</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>New weekly jobless claims held below 300,000 for a back-to-back week as labor market conditions trudged back toward pre-pandemic levels.\nTheLabor Department released its jobless claimsreport Thursday ...</p>\n\n<a href=\"https://finance.yahoo.com/news/weekly-jobless-claims-week-ended-october-16-2021-193313259.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FWRG":"First Watch Restaurant Group, Inc.","TERN":"Terns Pharmaceuticals, Inc.","CRCT":"Cricut, Inc.","OLPX":"Olaplex Holdings, Inc.","HCTI":"Healthcare Triangle, Inc."},"source_url":"https://finance.yahoo.com/news/weekly-jobless-claims-week-ended-october-16-2021-193313259.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2177468666","content_text":"New weekly jobless claims held below 300,000 for a back-to-back week as labor market conditions trudged back toward pre-pandemic levels.\nTheLabor Department released its jobless claimsreport Thursday morning. Here were the main metrics from the print, compared to consensus estimates compiled by Bloomberg:\n\nInitial unemployment claims, week ended October 16: 290,000 vs.297,000 expected and a revised296,000 during prior week\nContinuing claims, week ended October 9: 2.481 millionvs.2.548 million expected and a revised 2.603 million during prior week\n\nLast week's initial unemployment claims fell by a greater-than-expected margin, bringing the number of new filings back to the lowest level since March 2020. The four-week moving average for new jobless claims also dropped by 15,250 to reach 319,750 as of last week, also marking the least since March of last year.\nThe latest claims data reflects a labor market that has made considerable progress in reducing separations since its pandemic-era peak. However, it also still has a ways to go before returning entirely to pre-virus trends. In October 2020, new filings were coming in at a weekly rate of over 700,000, but in the same month in 2019, initial claims averaged just over 210,000.\n\nThe steady move lower in first-time filers so far this year has coincided with a jump in demand for labor and a reluctance by employers to release those already on their payrolls amid worker scarcities.\nBut many workers have also been departing their roles of their own volition. A record 4.3 million people quit their jobs in the U.S. in. August, based on the Labor Department's most recent data. And job openings overall were at a record high of more than 10.4 million as of the end of the summer.\n\"While mass layoffs have been avoided of late, helping jobless claims to decline, many who are employed feel some combination of empowerment, restlessness and/or exhaustion. This is borne out in the record number of workers quitting their jobs and strikes among union members popping up around the nation,\" Mark Hamrick, Bankrate senior economic analyst, wrote in an email on Tuesday.\n\"Making matters worse, inflation is eroding wage gains for some, fueling desire to find new employment with better pay, working conditions and flexibility,\" he added.\nContinuing jobless claims, capturing the number of individuals still claiming benefits via regular state programs, also reached a fresh pandemic-era low of 2.481 million as of early October. The insured unemployment rate, or the ratio of people on unemployment benefits divided by the overall force, dipped by 0.1 percentage points to reach 1.8% for the week ended Oct. 9.","news_type":1,"symbols_score_info":{"ALVU":0.9,"CRCT":0.9,"END":0.9,"FWRG":0.9,"HCTI":0.9,"OLPX":0.9,"TERN":0.9}},"isVote":1,"tweetType":1,"viewCount":495,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":863274441,"gmtCreate":1632403986783,"gmtModify":1632732572887,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks!","listText":"Please like, thanks!","text":"Please like, thanks!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/863274441","repostId":"1185114998","repostType":4,"repost":{"id":"1185114998","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632403944,"share":"https://www.laohu8.com/m/news/1185114998?lang=&edition=full","pubTime":"2021-09-23 21:32","market":"us","language":"en","title":"Stocks open higher, building on post-Fed gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1185114998","media":"Tiger Newspress","summary":"(Sept 23) Stocks open higher, building on post-Fed gains. Dow rises for a second day, adding 200 poi","content":"<p>(Sept 23)&nbsp;Stocks open higher, building on post-Fed gains.&nbsp;Dow rises for a second day, adding 200 points as market continues to reclaim September losses.</p>\n<p>The company reported better-than-expected quarterly earnings, with an adjusted gross margin of 65%. <a href=\"https://laohu8.com/S/BB\">BlackBerry</a> reported a loss of 6 cents per share, compared with the expected loss of 7 cents per share, according to Refinitiv. Revenue came in at $175 million, topping estimates of $164 million. Shares rose more than 9% in&nbsp;morning&nbsp;trding.</p>\n<p><img src=\"https://static.tigerbbs.com/db991fbc6c2ba939756396898e5220f5\" tg-width=\"959\" tg-height=\"561\" referrerpolicy=\"no-referrer\">Salesforce rose 4% after the cloud company raised its full-year 2022 revenue guidance.</p>\n<p><img src=\"https://static.tigerbbs.com/21871db96fdc1822b80c9e2903a14651\" tg-width=\"960\" tg-height=\"563\" width=\"100%\" height=\"auto\"></p>\n<p>Airline shares, Carnival stocks gain in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/70de15909e3e929a872f38ecc5bee841\" tg-width=\"276\" tg-height=\"361\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks open higher, building on post-Fed gains</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks open higher, building on post-Fed gains\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-23 21:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Sept 23)&nbsp;Stocks open higher, building on post-Fed gains.&nbsp;Dow rises for a second day, adding 200 points as market continues to reclaim September losses.</p>\n<p>The company reported better-than-expected quarterly earnings, with an adjusted gross margin of 65%. <a href=\"https://laohu8.com/S/BB\">BlackBerry</a> reported a loss of 6 cents per share, compared with the expected loss of 7 cents per share, according to Refinitiv. Revenue came in at $175 million, topping estimates of $164 million. Shares rose more than 9% in&nbsp;morning&nbsp;trding.</p>\n<p><img src=\"https://static.tigerbbs.com/db991fbc6c2ba939756396898e5220f5\" tg-width=\"959\" tg-height=\"561\" referrerpolicy=\"no-referrer\">Salesforce rose 4% after the cloud company raised its full-year 2022 revenue guidance.</p>\n<p><img src=\"https://static.tigerbbs.com/21871db96fdc1822b80c9e2903a14651\" tg-width=\"960\" tg-height=\"563\" width=\"100%\" height=\"auto\"></p>\n<p>Airline shares, Carnival stocks gain in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/70de15909e3e929a872f38ecc5bee841\" tg-width=\"276\" tg-height=\"361\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","SPY":"标普500ETF",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185114998","content_text":"(Sept 23) Stocks open higher, building on post-Fed gains. Dow rises for a second day, adding 200 points as market continues to reclaim September losses.\nThe company reported better-than-expected quarterly earnings, with an adjusted gross margin of 65%. BlackBerry reported a loss of 6 cents per share, compared with the expected loss of 7 cents per share, according to Refinitiv. Revenue came in at $175 million, topping estimates of $164 million. Shares rose more than 9% in morning trding.\nSalesforce rose 4% after the cloud company raised its full-year 2022 revenue guidance.\n\nAirline shares, Carnival stocks gain in morning trading.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"SPY":0.9}},"isVote":1,"tweetType":1,"viewCount":233,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":607925391,"gmtCreate":1639477651128,"gmtModify":1639477651495,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks!","listText":"Please like, thanks!","text":"Please like, thanks!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607925391","repostId":"1121800259","repostType":4,"isVote":1,"tweetType":1,"viewCount":2420,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":848459419,"gmtCreate":1636022326389,"gmtModify":1636022326796,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks!","listText":"Please like, thanks!","text":"Please like, thanks!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848459419","repostId":"1189037300","repostType":4,"repost":{"id":"1189037300","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1636018960,"share":"https://www.laohu8.com/m/news/1189037300?lang=&edition=full","pubTime":"2021-11-04 17:42","market":"us","language":"en","title":"5 Stocks To Watch For November 4, 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=1189037300","media":"Benzinga","summary":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Moderna, Inc. to rep","content":"<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Wall Street expects&nbsp;<b>Moderna, Inc.</b>&nbsp;to report quarterly earnings at $8.95 per share on revenue of $6.45 billion before the opening bell. Moderna shares rose 0.2% to $346.66 in pre-market trading.</li>\n <li><b>Booking Holdings Inc.</b>&nbsp;reported upbeat earnings for the third quarter. Booking shares gained 4.3% to $2,540.00 in the pre-market trading session.</li>\n <li>Analysts are expecting&nbsp;<b>ViacomCBS Inc.</b>&nbsp;to have earned $0.76 per share on revenue of $6.60 billion for the latest quarter. The company will release earnings before the markets open. ViacomCBS shares rose 0.7% to 37.80 in pre-market trading.</li>\n</ul>\n<ul>\n <li><b>Qualcomm Inc</b>&nbsp;posted upbeat results for its recent quarter and issued a strong forecast for its current quarter. Qualcomm shares climbed 6.7% to $147.80 in the pre-market trading session.</li>\n <li>Analysts expect&nbsp;<b>Airbnb, Inc.</b>&nbsp;to post quarterly earnings at $0.84 per share on revenue of $2.04 billion after the closing bell. Airbnb shares rose 2.2% to 176.64 in pre-market trading.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For November 4, 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For November 4, 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-11-04 17:42</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Wall Street expects&nbsp;<b>Moderna, Inc.</b>&nbsp;to report quarterly earnings at $8.95 per share on revenue of $6.45 billion before the opening bell. Moderna shares rose 0.2% to $346.66 in pre-market trading.</li>\n <li><b>Booking Holdings Inc.</b>&nbsp;reported upbeat earnings for the third quarter. Booking shares gained 4.3% to $2,540.00 in the pre-market trading session.</li>\n <li>Analysts are expecting&nbsp;<b>ViacomCBS Inc.</b>&nbsp;to have earned $0.76 per share on revenue of $6.60 billion for the latest quarter. The company will release earnings before the markets open. ViacomCBS shares rose 0.7% to 37.80 in pre-market trading.</li>\n</ul>\n<ul>\n <li><b>Qualcomm Inc</b>&nbsp;posted upbeat results for its recent quarter and issued a strong forecast for its current quarter. Qualcomm shares climbed 6.7% to $147.80 in the pre-market trading session.</li>\n <li>Analysts expect&nbsp;<b>Airbnb, Inc.</b>&nbsp;to post quarterly earnings at $0.84 per share on revenue of $2.04 billion after the closing bell. Airbnb shares rose 2.2% to 176.64 in pre-market trading.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BKNG":"Booking Holdings","MRNA":"Moderna, Inc.","QCOM":"高通","ABNB":"爱彼迎"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189037300","content_text":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Moderna, Inc. to report quarterly earnings at $8.95 per share on revenue of $6.45 billion before the opening bell. Moderna shares rose 0.2% to $346.66 in pre-market trading.\nBooking Holdings Inc. reported upbeat earnings for the third quarter. Booking shares gained 4.3% to $2,540.00 in the pre-market trading session.\nAnalysts are expecting ViacomCBS Inc. to have earned $0.76 per share on revenue of $6.60 billion for the latest quarter. The company will release earnings before the markets open. ViacomCBS shares rose 0.7% to 37.80 in pre-market trading.\n\n\nQualcomm Inc posted upbeat results for its recent quarter and issued a strong forecast for its current quarter. Qualcomm shares climbed 6.7% to $147.80 in the pre-market trading session.\nAnalysts expect Airbnb, Inc. to post quarterly earnings at $0.84 per share on revenue of $2.04 billion after the closing bell. Airbnb shares rose 2.2% to 176.64 in pre-market trading.","news_type":1,"symbols_score_info":{"ABNB":0.9,"BKNG":0.9,"MRNA":0.9,"QCOM":0.9,"VIAC":0.9}},"isVote":1,"tweetType":1,"viewCount":648,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":859078925,"gmtCreate":1634645766226,"gmtModify":1634645766630,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks!","listText":"Please like, thanks!","text":"Please like, thanks!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/859078925","repostId":"1185133403","repostType":4,"repost":{"id":"1185133403","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1634631070,"share":"https://www.laohu8.com/m/news/1185133403?lang=&edition=full","pubTime":"2021-10-19 16:11","market":"us","language":"en","title":"Alibaba rose nearly 2% in premarket trading as it unveils one of China’s most advanced chips","url":"https://stock-news.laohu8.com/highlight/detail?id=1185133403","media":"Tiger Newspress","summary":"Alibaba rose nearly 2% in premarket trading, and its stocks’ price in Hong Kong jumped 1.17% on Tuesday.The company unveiled a new server chip that’s based on advanced 5-nanometer technology, marking a milestone in China’s pursuit of semiconductor self-sufficiency.The newest chip is based on micro-architecture provided by the SoftBank Group Corp.-owned Arm Ltd., according to a statement Tuesday. Alibaba, which is holding its annual cloud summit in Hangzhou, said the silicon will be put to use in","content":"<p>Alibaba rose nearly 2% in premarket trading, and its stocks’ price in Hong Kong jumped 1.17% on Tuesday.</p>\n<p>&nbsp;<img src=\"https://static.tigerbbs.com/64d09abc429be4e1672683409ffa01e3\" tg-width=\"768\" tg-height=\"371\" width=\"100%\" height=\"auto\"></p>\n<p>The company unveiled a new server chip that’s based on advanced 5-nanometer technology, marking a milestone in China’s pursuit of semiconductor self-sufficiency.&nbsp;</p>\n<p>The newest chip is based on micro-architecture provided by the SoftBank Group Corp.-owned Arm Ltd., according to a statement Tuesday. Alibaba, which is holding its annual cloud summit in Hangzhou, said the silicon will be put to use in its own data centers in the “near future” and will not be sold commercially, at least for now.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba rose nearly 2% in premarket trading as it unveils one of China’s most advanced chips</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba rose nearly 2% in premarket trading as it unveils one of China’s most advanced chips\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-19 16:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Alibaba rose nearly 2% in premarket trading, and its stocks’ price in Hong Kong jumped 1.17% on Tuesday.</p>\n<p>&nbsp;<img src=\"https://static.tigerbbs.com/64d09abc429be4e1672683409ffa01e3\" tg-width=\"768\" tg-height=\"371\" width=\"100%\" height=\"auto\"></p>\n<p>The company unveiled a new server chip that’s based on advanced 5-nanometer technology, marking a milestone in China’s pursuit of semiconductor self-sufficiency.&nbsp;</p>\n<p>The newest chip is based on micro-architecture provided by the SoftBank Group Corp.-owned Arm Ltd., according to a statement Tuesday. Alibaba, which is holding its annual cloud summit in Hangzhou, said the silicon will be put to use in its own data centers in the “near future” and will not be sold commercially, at least for now.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BABA":"阿里巴巴","09988":"阿里巴巴-W"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185133403","content_text":"Alibaba rose nearly 2% in premarket trading, and its stocks’ price in Hong Kong jumped 1.17% on Tuesday.\n \nThe company unveiled a new server chip that’s based on advanced 5-nanometer technology, marking a milestone in China’s pursuit of semiconductor self-sufficiency. \nThe newest chip is based on micro-architecture provided by the SoftBank Group Corp.-owned Arm Ltd., according to a statement Tuesday. Alibaba, which is holding its annual cloud summit in Hangzhou, said the silicon will be put to use in its own data centers in the “near future” and will not be sold commercially, at least for now.","news_type":1,"symbols_score_info":{"09988":0.9,"BABA":0.9}},"isVote":1,"tweetType":1,"viewCount":631,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":821441428,"gmtCreate":1633780238117,"gmtModify":1633780238218,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thank you !","listText":"Please like, thank you !","text":"Please like, thank you !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/821441428","repostId":"1112605458","repostType":4,"repost":{"id":"1112605458","kind":"news","pubTimestamp":1633751161,"share":"https://www.laohu8.com/m/news/1112605458?lang=&edition=full","pubTime":"2021-10-09 11:46","market":"us","language":"en","title":"Fast-Growing Stocks: GOOGL Stock Among 24 Names Expecting Up To 800% Growth In Q3","url":"https://stock-news.laohu8.com/highlight/detail?id=1112605458","media":"investors","summary":"With Q3 earnings season on the horizon, here's a look at today's fastest-growing stocks expecting 65","content":"<p>With Q3 earnings season on the horizon, here's a look at today's fastest-growing stocks expecting 65% to 800% EPS increases in Q3 or their current fiscal quarter. Tech giant&nbsp;<b>Alphabet</b>(GOOGL) joins&nbsp;<b>Crocs</b>(CROX) and leading&nbsp;IPO&nbsp;<b>TaskUs</b>(TASK) make the cut.</p>\n<p><b>Steel Dynamics</b>(STLD) leads this&nbsp;stock screen&nbsp;featuring 24 companies, joined by&nbsp;oil stocks&nbsp;<b>Diamondback Energy</b>(FANG) and&nbsp;<b>Callon Petroleum</b>(CPE).</p>\n<p>Having only gone public in June, TASK stock is already among the best IPOs. TaskUs is on&nbsp;IBD Sector Leaders&nbsp;and joins&nbsp;GOOGL stock&nbsp;get on the&nbsp;IBD 50list of top growth stocks.&nbsp;<b>Atkore</b>(ATKR) and&nbsp;<b>Evercore</b>(EVR) also earn spots on the IBD 50 and this&nbsp;stock screen&nbsp;for today's fastest-growing companies.</p>\n<p>To make this screen, each stock must have a 95 or higher&nbsp;Composite Rating&nbsp;and an 80 or better EPS and RS rating. To avoid thinly traded stocks, the stocks must trade at least 400,000 shares a day on average.</p>\n<p>Fastest-Growing Stocks Test Support And Resistance</p>\n<p>With the stock market in a correction, now is not an ideal time to buy stocks. But GOOGL stock, Diamondback Energy, Atkore and others are trying to bounce back as the indexes look to launch a&nbsp;follow-through day&nbsp;to improve the&nbsp;market outlook.</p>\n<p>CROX stock, GOOGL stock and others are testing support and resistance at their10-week moving averages.</p>\n<p>Although this is not an ideal time to&nbsp;buy stocks, the market can turn on a dime. So continue to build your watchlist to track the fastest-growing stocks that may be building new&nbsp;chart patterns&nbsp;and establishing fresh&nbsp;buy points&nbsp;for when the market rebounds.</p>\n<p>Q3 Earnings: Best Growth Stocks To WatchScreen generated in&nbsp;MarketSmith| Data as of 10/7/21</p>\n<table>\n <thead>\n  <tr>\n   <th>Company</th>\n   <th>Symbol</th>\n   <th>EPS Est Cur Qtr %</th>\n   <th>Comp Rating</th>\n   <th>EPS Rating</th>\n   <th>RS Rating</th>\n   <th>SMR Rating</th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td>Steel Dynamics Inc</td>\n   <td>STLD</td>\n   <td>800</td>\n   <td>95</td>\n   <td>95</td>\n   <td>84</td>\n   <td>A</td>\n  </tr>\n  <tr>\n   <td>Boot Barn Holdings Inc</td>\n   <td>BOOT</td>\n   <td>345</td>\n   <td>99</td>\n   <td>98</td>\n   <td>96</td>\n   <td>A</td>\n  </tr>\n  <tr>\n   <td>Northeast Bank</td>\n   <td>NBN</td>\n   <td>332</td>\n   <td>98</td>\n   <td>99</td>\n   <td>94</td>\n   <td>A</td>\n  </tr>\n  <tr>\n   <td>Diamondback Energy Inc</td>\n   <td>FANG</td>\n   <td>329</td>\n   <td>99</td>\n   <td>94</td>\n   <td>97</td>\n   <td>A</td>\n  </tr>\n  <tr>\n   <td>Callon Petroleum Co</td>\n   <td>CPE</td>\n   <td>281</td>\n   <td>98</td>\n   <td>85</td>\n   <td>99</td>\n   <td>A</td>\n  </tr>\n  <tr>\n   <td>Atkore Inc</td>\n   <td>ATKR</td>\n   <td>224</td>\n   <td>99</td>\n   <td>99</td>\n   <td>97</td>\n   <td>A</td>\n  </tr>\n  <tr>\n   <td>Encore Wire Corp</td>\n   <td>WIRE</td>\n   <td>186</td>\n   <td>99</td>\n   <td>98</td>\n   <td>95</td>\n   <td>A</td>\n  </tr>\n  <tr>\n   <td>Matson Inc</td>\n   <td>MATX</td>\n   <td>170</td>\n   <td>99</td>\n   <td>95</td>\n   <td>91</td>\n   <td>A</td>\n  </tr>\n  <tr>\n   <td>Evercore Inc</td>\n   <td>EVR</td>\n   <td>151</td>\n   <td>96</td>\n   <td>96</td>\n   <td>86</td>\n   <td>A</td>\n  </tr>\n  <tr>\n   <td>C A I International Inc</td>\n   <td>CAI</td>\n   <td>126</td>\n   <td>98</td>\n   <td>98</td>\n   <td>91</td>\n   <td>A</td>\n  </tr>\n  <tr>\n   <td>Virtus Investment Ptnrs</td>\n   <td>VRTS</td>\n   <td>114</td>\n   <td>99</td>\n   <td>99</td>\n   <td>93</td>\n   <td>A</td>\n  </tr>\n  <tr>\n   <td>Moelis &amp; Company Cl A</td>\n   <td>MC</td>\n   <td>104</td>\n   <td>96</td>\n   <td>81</td>\n   <td>92</td>\n   <td>A</td>\n  </tr>\n  <tr>\n   <td>Builders Firstsource Inc</td>\n   <td>BLDR</td>\n   <td>100</td>\n   <td>98</td>\n   <td>99</td>\n   <td>87</td>\n   <td>A</td>\n  </tr>\n  <tr>\n   <td>Skyline Champion Corp</td>\n   <td>SKY</td>\n   <td>100</td>\n   <td>97</td>\n   <td>99</td>\n   <td>94</td>\n   <td>A</td>\n  </tr>\n  <tr>\n   <td>Silvergate Cap Corp Cl A</td>\n   <td>SI</td>\n   <td>97</td>\n   <td>99</td>\n   <td>99</td>\n   <td>99</td>\n   <td>A</td>\n  </tr>\n  <tr>\n   <td>Crocs Inc</td>\n   <td>CROX</td>\n   <td>96</td>\n   <td>99</td>\n   <td>99</td>\n   <td>97</td>\n   <td>A</td>\n  </tr>\n  <tr>\n   <td>Power Integrations Inc</td>\n   <td>POWI</td>\n   <td>95</td>\n   <td>98</td>\n   <td>87</td>\n   <td>88</td>\n   <td>A</td>\n  </tr>\n  <tr>\n   <td>N A P C O Security Tech</td>\n   <td>NSSC</td>\n   <td>92</td>\n   <td>96</td>\n   <td>92</td>\n   <td>92</td>\n   <td>A</td>\n  </tr>\n  <tr>\n   <td>Taskus Inc Class A</td>\n   <td>TASK</td>\n   <td>88</td>\n   <td>99</td>\n   <td>98</td>\n   <td>98</td>\n   <td>A</td>\n  </tr>\n  <tr>\n   <td>Techtarget Inc</td>\n   <td>TTGT</td>\n   <td>83</td>\n   <td>99</td>\n   <td>99</td>\n   <td>87</td>\n   <td>A</td>\n  </tr>\n  <tr>\n   <td>Headhunter Group Plc Ads</td>\n   <td>HHR</td>\n   <td>76</td>\n   <td>99</td>\n   <td>93</td>\n   <td>95</td>\n   <td>A</td>\n  </tr>\n  <tr>\n   <td>Endava Plc Cl A Ads</td>\n   <td>DAVA</td>\n   <td>71</td>\n   <td>99</td>\n   <td>98</td>\n   <td>96</td>\n   <td>A</td>\n  </tr>\n  <tr>\n   <td>Metrocity Bankshares Inc</td>\n   <td>MCBS</td>\n   <td>69</td>\n   <td>95</td>\n   <td>90</td>\n   <td>90</td>\n   <td>A</td>\n  </tr>\n  <tr>\n   <td>Alphabet Inc Cl A</td>\n   <td>GOOGL</td>\n   <td>65</td>\n   <td>99</td>\n   <td>98</td>\n   <td>91</td>\n   <td>A</td>\n  </tr>\n </tbody>\n</table>","source":"lsy1610449120050","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fast-Growing Stocks: GOOGL Stock Among 24 Names Expecting Up To 800% Growth In Q3</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFast-Growing Stocks: GOOGL Stock Among 24 Names Expecting Up To 800% Growth In Q3\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-09 11:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.investors.com/research/fast-growing-stocks-q3-earnings-estimates/?src=A00220><strong>investors</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>With Q3 earnings season on the horizon, here's a look at today's fastest-growing stocks expecting 65% to 800% EPS increases in Q3 or their current fiscal quarter. Tech giant Alphabet(GOOGL) joins ...</p>\n\n<a href=\"https://www.investors.com/research/fast-growing-stocks-q3-earnings-estimates/?src=A00220\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STLD":"Steel Dynamics","CROX":"卡骆驰","TASK":"TaskUs Inc.","GOOGL":"谷歌A","FANG":"Diamondback Energy","CPE":"卡隆石油"},"source_url":"https://www.investors.com/research/fast-growing-stocks-q3-earnings-estimates/?src=A00220","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1112605458","content_text":"With Q3 earnings season on the horizon, here's a look at today's fastest-growing stocks expecting 65% to 800% EPS increases in Q3 or their current fiscal quarter. Tech giant Alphabet(GOOGL) joins Crocs(CROX) and leading IPO TaskUs(TASK) make the cut.\nSteel Dynamics(STLD) leads this stock screen featuring 24 companies, joined by oil stocks Diamondback Energy(FANG) and Callon Petroleum(CPE).\nHaving only gone public in June, TASK stock is already among the best IPOs. TaskUs is on IBD Sector Leaders and joins GOOGL stock get on the IBD 50list of top growth stocks. Atkore(ATKR) and Evercore(EVR) also earn spots on the IBD 50 and this stock screen for today's fastest-growing companies.\nTo make this screen, each stock must have a 95 or higher Composite Rating and an 80 or better EPS and RS rating. To avoid thinly traded stocks, the stocks must trade at least 400,000 shares a day on average.\nFastest-Growing Stocks Test Support And Resistance\nWith the stock market in a correction, now is not an ideal time to buy stocks. But GOOGL stock, Diamondback Energy, Atkore and others are trying to bounce back as the indexes look to launch a follow-through day to improve the market outlook.\nCROX stock, GOOGL stock and others are testing support and resistance at their10-week moving averages.\nAlthough this is not an ideal time to buy stocks, the market can turn on a dime. So continue to build your watchlist to track the fastest-growing stocks that may be building new chart patterns and establishing fresh buy points for when the market rebounds.\nQ3 Earnings: Best Growth Stocks To WatchScreen generated in MarketSmith| Data as of 10/7/21\n\n\n\nCompany\nSymbol\nEPS Est Cur Qtr %\nComp Rating\nEPS Rating\nRS Rating\nSMR Rating\n\n\n\n\nSteel Dynamics Inc\nSTLD\n800\n95\n95\n84\nA\n\n\nBoot Barn Holdings Inc\nBOOT\n345\n99\n98\n96\nA\n\n\nNortheast Bank\nNBN\n332\n98\n99\n94\nA\n\n\nDiamondback Energy Inc\nFANG\n329\n99\n94\n97\nA\n\n\nCallon Petroleum Co\nCPE\n281\n98\n85\n99\nA\n\n\nAtkore Inc\nATKR\n224\n99\n99\n97\nA\n\n\nEncore Wire Corp\nWIRE\n186\n99\n98\n95\nA\n\n\nMatson Inc\nMATX\n170\n99\n95\n91\nA\n\n\nEvercore Inc\nEVR\n151\n96\n96\n86\nA\n\n\nC A I International Inc\nCAI\n126\n98\n98\n91\nA\n\n\nVirtus Investment Ptnrs\nVRTS\n114\n99\n99\n93\nA\n\n\nMoelis & Company Cl A\nMC\n104\n96\n81\n92\nA\n\n\nBuilders Firstsource Inc\nBLDR\n100\n98\n99\n87\nA\n\n\nSkyline Champion Corp\nSKY\n100\n97\n99\n94\nA\n\n\nSilvergate Cap Corp Cl A\nSI\n97\n99\n99\n99\nA\n\n\nCrocs Inc\nCROX\n96\n99\n99\n97\nA\n\n\nPower Integrations Inc\nPOWI\n95\n98\n87\n88\nA\n\n\nN A P C O Security Tech\nNSSC\n92\n96\n92\n92\nA\n\n\nTaskus Inc Class A\nTASK\n88\n99\n98\n98\nA\n\n\nTechtarget Inc\nTTGT\n83\n99\n99\n87\nA\n\n\nHeadhunter Group Plc Ads\nHHR\n76\n99\n93\n95\nA\n\n\nEndava Plc Cl A Ads\nDAVA\n71\n99\n98\n96\nA\n\n\nMetrocity Bankshares Inc\nMCBS\n69\n95\n90\n90\nA\n\n\nAlphabet Inc Cl A\nGOOGL\n65\n99\n98\n91\nA","news_type":1,"symbols_score_info":{"CPE":0.9,"CROX":0.9,"FANG":0.9,"GOOGL":0.9,"STLD":0.9,"TASK":0.9}},"isVote":1,"tweetType":1,"viewCount":660,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":821441179,"gmtCreate":1633780107457,"gmtModify":1633780107563,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks!","listText":"Please like, thanks!","text":"Please like, thanks!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/821441179","repostId":"2174920514","repostType":4,"isVote":1,"tweetType":1,"viewCount":359,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601667375,"gmtCreate":1638523686919,"gmtModify":1638523690134,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks","listText":"Please like, thanks","text":"Please like, thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/601667375","repostId":"1154256555","repostType":4,"repost":{"id":"1154256555","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638523084,"share":"https://www.laohu8.com/m/news/1154256555?lang=&edition=full","pubTime":"2021-12-03 17:18","market":"us","language":"en","title":"Novavax stock surged more than 7% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1154256555","media":"Tiger Newspress","summary":"Novavax stock surged more than 7% in premarket trading as Novavax said it could start making Omicron","content":"<p>Novavax stock surged more than 7% in premarket trading&nbsp;as&nbsp;Novavax said it could start making Omicron-specific vaccine in January.</p>\n<p><img src=\"https://static.tigerbbs.com/25019bf4a8dc635b8734c21361f7c7d0\" tg-width=\"852\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p>\n<p>Novavax Inc&nbsp;said on Thursday it could begin commercial manufacturing of a COVID-19 vaccine tailored for the Omicron coronavirus variant in January next year, while it tests whether or not its current vaccine works against the variant.</p>\n<p>Laboratory data expected in the coming weeks will show whether antibodies from individuals who have previously received Novavax's COVID-19 shot can neutralize the variant, according to the company.</p>\n<p>Novavax also said it has started developing an Omicron-specific spike protein antigen and will begin laboratory tests of a new vaccine to target the variant in a few weeks.</p>\n<p>The Omicron coronavirus variant has shaken up markets and caused global alarm over concerns about whether it could evade protection provided by widely used vaccines and prolong the public health crisis.</p>\n<p>Other vaccine makers including Moderna&nbsp;and Pfizer&nbsp;have also begun working on Omicron-tailored COVID-19 shots.</p>\n<p>Novavax's COVID-19 vaccine received its first emergency use approval in Indonesia in early November followed by the Philippines.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax stock surged more than 7% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax stock surged more than 7% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-03 17:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax stock surged more than 7% in premarket trading&nbsp;as&nbsp;Novavax said it could start making Omicron-specific vaccine in January.</p>\n<p><img src=\"https://static.tigerbbs.com/25019bf4a8dc635b8734c21361f7c7d0\" tg-width=\"852\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p>\n<p>Novavax Inc&nbsp;said on Thursday it could begin commercial manufacturing of a COVID-19 vaccine tailored for the Omicron coronavirus variant in January next year, while it tests whether or not its current vaccine works against the variant.</p>\n<p>Laboratory data expected in the coming weeks will show whether antibodies from individuals who have previously received Novavax's COVID-19 shot can neutralize the variant, according to the company.</p>\n<p>Novavax also said it has started developing an Omicron-specific spike protein antigen and will begin laboratory tests of a new vaccine to target the variant in a few weeks.</p>\n<p>The Omicron coronavirus variant has shaken up markets and caused global alarm over concerns about whether it could evade protection provided by widely used vaccines and prolong the public health crisis.</p>\n<p>Other vaccine makers including Moderna&nbsp;and Pfizer&nbsp;have also begun working on Omicron-tailored COVID-19 shots.</p>\n<p>Novavax's COVID-19 vaccine received its first emergency use approval in Indonesia in early November followed by the Philippines.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154256555","content_text":"Novavax stock surged more than 7% in premarket trading as Novavax said it could start making Omicron-specific vaccine in January.\n\nNovavax Inc said on Thursday it could begin commercial manufacturing of a COVID-19 vaccine tailored for the Omicron coronavirus variant in January next year, while it tests whether or not its current vaccine works against the variant.\nLaboratory data expected in the coming weeks will show whether antibodies from individuals who have previously received Novavax's COVID-19 shot can neutralize the variant, according to the company.\nNovavax also said it has started developing an Omicron-specific spike protein antigen and will begin laboratory tests of a new vaccine to target the variant in a few weeks.\nThe Omicron coronavirus variant has shaken up markets and caused global alarm over concerns about whether it could evade protection provided by widely used vaccines and prolong the public health crisis.\nOther vaccine makers including Moderna and Pfizer have also begun working on Omicron-tailored COVID-19 shots.\nNovavax's COVID-19 vaccine received its first emergency use approval in Indonesia in early November followed by the Philippines.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":3196,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877285184,"gmtCreate":1637936240818,"gmtModify":1637936240989,"author":{"id":"4088005490387040","authorId":"4088005490387040","name":"KCmax","avatar":"https://static.tigerbbs.com/45501c3f0f17a005aaae037440a22212","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088005490387040","authorIdStr":"4088005490387040"},"themes":[],"htmlText":"Please like, thanks","listText":"Please like, thanks","text":"Please like, thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877285184","repostId":"1145084508","repostType":4,"isVote":1,"tweetType":1,"viewCount":454,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}